https://curecurrent.com/trials/enhancing-adherence-by-building-online-communities-24001https://curecurrent.com/trials/effect-of-the-known-antihypertensive-drug-telmisartan-on-red-blood-cells-and-circulation-in-the-smallest-blood-vessels-24002https://curecurrent.com/trials/endothelial-function-in-a-sample-group-of-patients-from-the-icare-study-24003https://curecurrent.com/trials/clinical-trial-of-footwear-in-patients-with-diabetes-24004https://curecurrent.com/trials/development-implementation-and-evaluation-of-a-complex-regional-intervention-for-type-2-diabetes-diabetes-project-aalst-24005https://curecurrent.com/trials/the-epidemiology-of-aortic-diameter-in-china-24006https://curecurrent.com/trials/study-of-the-relationship-between-sleep-quality-and-daytime-nighttime-variations-of-blood-pressure-and-plasma-glucose-ty-24007https://curecurrent.com/trials/blood-sugar-response-to-commercial-nutritional-supplements-in-patients-with-type-2-diabetes-24008https://curecurrent.com/trials/the-necessity-of-an-injection-meal-interval-in-patients-with-type-2-diabetes-mellitus-and-therapy-with-human-insulin-24009https://curecurrent.com/trials/blood-glucose-homeostasis-in-type-2-diabetes-the-effects-of-saccharose-24010https://curecurrent.com/trials/effect-of-green-tea-extract-on-type-2-diabetes-24011https://curecurrent.com/trials/chromogranin-a-derived-peptides-and-periodontitis-in-diabetic-patients-24012https://curecurrent.com/trials/differential-effects-of-protein-quality-on-postprandial-lipemia-in-response-to-a-fat-rich-meal-in-type-2-diabetes-compar-24013https://curecurrent.com/trials/differential-effects-of-milk-proteins-on-postprandial-lipemia-in-response-to-a-fat-rich-meal-in-type-2-diabetes-24014https://curecurrent.com/trials/prevention-of-instent-renarrowing-with-aggressive-glucose-lowering-with-pioglitazone-in-diabetic-patients-24015https://curecurrent.com/trials/low-intermediate-glycemic-index-caribbean-foods-versus-high-glycemic-index-foods-in-type-2-diabetes-24016https://curecurrent.com/trials/long-term-safety-study-of-vildagliptin-in-patients-with-type-2-diabetes-24017https://curecurrent.com/trials/the-impact-of-rosiglitazone-on-regression-of-atherosclerosis-24018https://curecurrent.com/trials/the-effects-of-resistance-exercises-in-glycemic-control-of-women-with-gestational-diabetes-24019https://curecurrent.com/trials/effects-of-inspiratory-muscle-training-on-type-2-diabetes-mellitus-patients-with-inspiratory-muscle-weakness-24020https://curecurrent.com/trials/the-relationship-between-stage-of-diabetic-retinopathy-and-retinal-blood-flow-in-patients-with-iddm-during-euglycemic-cl-24021https://curecurrent.com/trials/resistance-exercise-training-during-pregnancy-a-randomized-controlled-trial-24022https://curecurrent.com/trials/evaluation-of-a-novel-method-for-integrating-insulin-delivery-and-glucose-sensing-in-adipose-tissue-of-diabetic-patients-24023https://curecurrent.com/trials/effect-of-diabetes-control-on-outcome-in-hospitalized-patients-a-national-israeli-study-24024https://curecurrent.com/trials/a-randomized-trial-of-electronic-integration-of-care-for-better-diabetes-outcomes-the-compete-ii-study-24025https://curecurrent.com/trials/eeg-changes-during-insulininduced-hypoglycemia-in-type-1-diabetes-24026https://curecurrent.com/trials/a-randomised-single-centre-double-blind-two-period-crossover-glucose-clamp-trial-24027https://curecurrent.com/trials/phone-call-in-type-2-diabetes-patient-24028https://curecurrent.com/trials/a-study-in-patients-with-diabetes-mellitus-type-ii-of-the-effect-on-albuminuria-of-24-week-treatment-with-valsartan-bena-24029https://curecurrent.com/trials/acupuncture-for-diabetic-gastroparesis-24030https://curecurrent.com/trials/efficacy-of-n-acetylcysteine-in-prevention-of-post-catheterization-contrast-induced-nephropathy-in-diabetic-patients-wit-24031https://curecurrent.com/trials/exercise-and-diet-in-type-2-diabetic-women-24032https://curecurrent.com/trials/improvement-of-insulin-resistance-with-traditional-chinese-treatment-in-patients-with-type-2-diabetes-24033https://curecurrent.com/trials/comparison-of-novo-rapid-30-mix-injection-flexpen-and-humalog-25-mix-injection-kwikpen-in-type-2-diabetic-patients-24034https://curecurrent.com/trials/effectiveness-of-oral-acetazolamide-brimonidine-tartarate-and-anterior-chamber-paracentesis-in-intraocular-pressure-iop-24035https://curecurrent.com/trials/effect-of-metformin-versus-repaglinide-treatment-in-non-obese-type-2-diabetic-patients-uncontrolled-by-diet-24036https://curecurrent.com/trials/changes-in-cardiovascular-hemodynamics-during-peritoneal-dialysis-24037https://curecurrent.com/trials/effect-of-repaglinide-versus-metformin-treatment-in-non-obese-patients-with-type-2-diabetes-24038https://curecurrent.com/trials/childhood-diabetes-24039https://curecurrent.com/trials/effect-of-metformin-in-patients-with-type-1-diabetes-with-inadequate-glycaemic-control-by-insulin-and-diet-24040https://curecurrent.com/trials/asp-8825-study-in-patients-with-painful-diabetic-polyneuropathy-24041https://curecurrent.com/trials/phenotype-evaluation-in-insulin-naive-patients-using-lantus-insulin-glargine-24042https://curecurrent.com/trials/long-term-safety-of-vildagliptin-100mg-qd-in-patients-with-type-2-diabetes-24043https://curecurrent.com/trials/can-structured-education-promote-physical-activity-in-those-identified-with-an-increased-risk-of-developing-diabetes-24044https://curecurrent.com/trials/phase-iia-study-to-investigate-the-efficacy-and-safety-of-spp635-in-diabetic-and-hypertensive-patients-with-albuminuria-24045https://curecurrent.com/trials/prospective-randomized-trials-of-gastric-bypass-surgery-in-patients-with-type-ii-diabetes-mellitus-24046https://curecurrent.com/trials/mediterranean-diet-and-postprandial-lipemia-24047https://curecurrent.com/trials/renin-angiotensin-system-study-rass-b-rass-24048https://curecurrent.com/trials/glitazones-and-endothelial-function-gate-24049https://curecurrent.com/trials/evaluation-study-for-the-programme-diane-for-people-with-diabetic-nephropathy-24050https://curecurrent.com/trials/lifestyle-intervention-in-obese-arab-women-24051https://curecurrent.com/trials/growth-hormone-treatment-in-men-with-high-risk-of-developing-type-2-diabetes-mellitus-24052https://curecurrent.com/trials/bioequivalence-study-of-glucotrol-xl-2-5-mg-tablets-24053https://curecurrent.com/trials/double-blind-comparison-between-mitiglinide-and-nateglinide-in-type-2-diabetic-patients-24054https://curecurrent.com/trials/randomized-controlled-trial-of-insulin-versus-tablets-for-latent-autoimmune-diabetes-in-adults-lada-24055https://curecurrent.com/trials/adiponectin-and-insulin-resistance-in-diabetic-nephropathy-24056https://curecurrent.com/trials/nerve-entrapment-in-diabetic-patients-24057https://curecurrent.com/trials/effects-of-a-multi-faceted-psychiatric-intervention-targeted-at-the-complex-medically-ill-a-randomized-controlled-trial-24058https://curecurrent.com/trials/hyperbaric-oxygen-oxidative-stress-no-bioavailability-and-tissue-oxygenation-24059https://curecurrent.com/trials/a-safety-and-efficacy-study-with-ym543-in-type-2-diabetes-mellitus-subjects-24060https://curecurrent.com/trials/cardiovascular-cv-risk-evaluation-in-type-2-diabetes-subjects-24061https://curecurrent.com/trials/beta-cell-function-tests-over-time-in-patients-with-t2dm-randomized-to-metformin-or-rosiglitazone-24062https://curecurrent.com/trials/open-trial-of-miglitol-in-type-2-diabetic-patients-treated-with-biguanide-24063https://curecurrent.com/trials/double-blind-trial-of-miglitol-in-type-2-diabetic-patients-treated-with-biguanide-24064https://curecurrent.com/trials/phase-ii-dose-finding-study-of-sk-0403-with-type-2-diabetes-mellitus-24065https://curecurrent.com/trials/vein-coronary-atherosclerosis-and-rosiglitazone-after-bypass-surgery-the-victory-trial-24066https://curecurrent.com/trials/effect-of-metformin-on-lactate-metabolism-24067https://curecurrent.com/trials/preoperative-bevacizumab-for-vitreous-hemorrhage-24068https://curecurrent.com/trials/a-cohort-study-of-morning-home-blood-pressure-measurement-in-type-2-diabetic-patients-24069https://curecurrent.com/trials/signaling-mechanisms-and-vascular-function-in-diabetes-mellitus-24070https://curecurrent.com/trials/extension-of-phase-ii-therapeutic-trial-with-a-humanized-non-mitogenic-cd3-chagly-cd3-monoclonal-antibody-in-recently-di-24071https://curecurrent.com/trials/a-study-to-evaluate-pf-00915275-in-subjects-with-type-2-diabetes-mellitus-for-4-weeks-24072https://curecurrent.com/trials/glycemic-rises-after-waking-up-in-response-to-an-alarm-clock-in-type-1-diabetic-patients-analysed-with-continuous-glucos-24073https://curecurrent.com/trials/genetic-variants-and-phenotypic-characteristics-of-patients-with-t2dm-24074https://curecurrent.com/trials/the-cosmos-study-copeptin-in-osmoregulation-and-stress-assessment-24075https://curecurrent.com/trials/inspiratory-muscle-training-in-patients-with-autonomic-neuropathic-24076https://curecurrent.com/trials/non-invasive-assessment-of-liver-glycogen-kinetics-and-atp-synthesis-in-type1-diabetics-24077https://curecurrent.com/trials/increasing-screening-for-type-2-diabetes-in-women-with-previous-gestational-diabetes-24078https://curecurrent.com/trials/insulin-effects-on-metabolism-and-cardiovascular-function-in-type-2-diabetes-24079https://curecurrent.com/trials/insulin-glargine-benefits-in-japanese-pts-outside-of-japan-us-or-brazil-24080https://curecurrent.com/trials/coronary-computed-tomography-angiography-and-spect-in-asymptomatic-diabetes-24081https://curecurrent.com/trials/a-phase-2-study-to-determine-the-effects-of-bxt-51072-in-diabetic-patients-undergoing-angioplasty-pci-24082https://curecurrent.com/trials/the-study-of-atherosclerosis-with-ramipril-and-rosiglitazone-24083https://curecurrent.com/trials/insulin-glargine-initiate-metabolic-and-economic-outcomes-of-lantus-24084https://curecurrent.com/trials/feasibility-study-of-the-effect-of-intra-dermal-insulin-injection-on-blood-glucose-levels-after-eating-24085https://curecurrent.com/trials/histidine-tryptophane-ketoglutarate-htk-vs-university-of-wisconsin-uw-perfusion-in-clinical-pancreas-transplantation-24086https://curecurrent.com/trials/efficacy-of-telmisartan-and-the-combination-of-telmisartan-and-ramipril-in-type1-diabetes-patients-with-nephropathy-24087https://curecurrent.com/trials/effect-of-short-term-exercise-training-on-atp-synthesis-in-relatives-of-type-2-diabetic-humans-24088https://curecurrent.com/trials/the-effect-of-folic-acid-administration-in-the-progression-of-microalbuminuria-24089https://curecurrent.com/trials/safety-study-of-isis-325568-in-healthy-volunteers-24090https://curecurrent.com/trials/fenofibrate-and-metformin-insulin-sensitivity-in-type-2-diabetics-study-24091https://curecurrent.com/trials/aliskiren-s-effect-on-arterial-stiffness-and-platelet-function-in-patients-with-diabetes-mellitus-dm-24092https://curecurrent.com/trials/hematopoietic-stem-cell-transplantation-for-the-treatment-of-limb-ischemia-and-diabetic-neuropathy-24093https://curecurrent.com/trials/evaluation-of-education-in-the-secondary-prevention-of-foot-ulceration-in-diabetes-24094https://curecurrent.com/trials/blood-glucose-response-to-highly-viscous-polysaccharide-enriched-biscuits-in-healthy-and-diabetic-subjects-24095https://curecurrent.com/trials/evaluation-of-dermstream-tm-an-irrigation-product-for-chronic-wound-management-24096https://curecurrent.com/trials/pioglitazone-for-prevention-of-restenosis-in-diabetic-patients-24097https://curecurrent.com/trials/dietary-control-of-type-2-diabetes-low-carbohydrate-mediterranean-diet-versus-low-fat-diet-24098https://curecurrent.com/trials/tarka-vs-lotrel-in-hypertensive-diabetic-subjects-with-renal-disease-tandem-24099https://curecurrent.com/trials/a-study-for-prevention-of-kidney-disease-in-diabetic-patients-benedict-24100https://curecurrent.com/trials/insulin-detemir-and-waist-circumference-24101https://curecurrent.com/trials/glp-1-infusion-and-long-time-fasting-24102https://curecurrent.com/trials/assessing-the-effectiveness-of-diabetes-interactive-diary-did-in-diabetes-management-24103https://curecurrent.com/trials/a-study-for-patients-with-type-2-diabetes-mellitus-24104https://curecurrent.com/trials/skittles-tm-effective-for-treating-hypoglycemia-in-children-with-type-1-diabetes-24105https://curecurrent.com/trials/the-effect-of-calcium-supplementation-on-insulin-resistance-and-24h-blood-pressure-24106https://curecurrent.com/trials/correlation-of-flicker-induced-and-flow-mediated-vasodilatation-in-patients-with-endothelial-dysfunction-and-healthy-vol-24107https://curecurrent.com/trials/the-influence-of-fatty-acids-on-systemic-and-subcutaneous-cytokines-24108https://curecurrent.com/trials/safety-and-efficacy-of-autologous-adipose-derived-stem-cell-transplantation-in-patients-with-type-1-diabetes-24109https://curecurrent.com/trials/safety-and-efficacy-of-autologous-adipose-derived-stem-cell-transplantation-in-type-2-diabetics-24110https://curecurrent.com/trials/thymoglobulin-in-calcineurin-inhibitor-and-steroid-minimization-protocol-24111https://curecurrent.com/trials/fenofibrate-and-metformin-fixed-combination-vs-rosiglitazone-fame-rosi-24112https://curecurrent.com/trials/intravitreal-bevacizumab-for-management-of-active-progressive-proliferative-diabetic-retinopathy-pdr-24113https://curecurrent.com/trials/glucagon-responses-during-oral-and-iv-glucose-in-patients-with-type-1-diabetes-24114https://curecurrent.com/trials/a-randomized-double-blind-trial-comparing-the-efficacy-and-safety-of-fenofibrate-metformin-their-combination-and-placebo-24115https://curecurrent.com/trials/a-randomised-double-blind-placebo-controlled-study-assessing-the-effect-of-fenofibrate-coenzyme-q10-and-their-co-adminis-24116https://curecurrent.com/trials/body-composition-glucose-metabolism-insulin-resistance-and-gene-expression-in-muscle-cells-in-healthy-overweight-women-24117https://curecurrent.com/trials/does-simvastatin-affect-insulin-sensitivity-in-dyslipidemic-type-2-diabetic-patients-24118https://curecurrent.com/trials/intravitreal-bevacizumab-for-diabetic-macular-edema-24119https://curecurrent.com/trials/south-danish-diabetes-study-evaluation-of-the-antidiabetic-treatment-of-type-2-diabetes-mellitus-24120https://curecurrent.com/trials/12-week-comparing-safety-of-hmr1964-insulin-aspart-used-in-continuous-subcutaneous-infusion-in-type-1-diabetes-24121https://curecurrent.com/trials/survey-of-thai-muslim-health-status-24122https://curecurrent.com/trials/effects-of-cranberry-extractive-on-the-lipid-profiles-in-subjects-with-type-2-diabetes-24123https://curecurrent.com/trials/i3lte4-intensive-insulin-therapy-and-production-of-lte4-in-patients-with-diabetes-24124https://curecurrent.com/trials/the-effect-of-sitagliptin-on-hypertension-arterial-stiffness-oxidative-stress-and-inflammation-24125https://curecurrent.com/trials/gene-expression-profiling-and-bioinformatic-analysis-identifying-genes-and-biochemical-pathways-in-type-2-diabetes-24126https://curecurrent.com/trials/the-effect-of-glp-1-on-glucose-uptake-in-the-brain-and-heart-in-healthy-men-during-hypoglycemia-24127https://curecurrent.com/trials/oxidative-stress-lowering-effect-of-simvastatin-and-atorvastatin-24128https://curecurrent.com/trials/laboratory-aspirin-resistance-in-diabetics-and-non-diabetics-24129https://curecurrent.com/trials/pars-plana-vitrectomy-ppv-versus-preoperative-intravitreal-bevacizumab-plus-ppv-to-treat-diabetic-tractional-retinal-det-24130https://curecurrent.com/trials/autoregulation-of-glomerular-filtration-rate-in-patients-with-type-1-diabetes-during-spironolactone-therapy-24131https://curecurrent.com/trials/effect-of-the-omentectomy-on-the-hyperglycemia-and-the-resistance-to-the-insulin-in-patients-with-morbid-obesity-24132https://curecurrent.com/trials/alpha-cell-sensitivity-to-glp-1-in-patients-with-type-2-diabetes-24133https://curecurrent.com/trials/acute-viral-hepatitis-and-diabetes-mellitus-24134https://curecurrent.com/trials/moderate-alcohol-consumption-fat-and-carbohydrate-metabolism-and-insulin-sensitivity-24135https://curecurrent.com/trials/vitamin-d-supplementation-to-patients-with-type-2-diabetes-24136https://curecurrent.com/trials/effects-of-polyphenol-containing-antioxidants-on-oxidative-stress-in-diabetic-patients-24137https://curecurrent.com/trials/diabetes-mellitus-and-vulvovaginal-candidiasis-24138https://curecurrent.com/trials/impact-of-benfluorex-versus-metformin-on-glucose-control-and-insulin-secretion-in-chinese-type-2-diabetic-patients-24139https://curecurrent.com/trials/study-of-gene-activity-in-fat-and-muscle-in-diabetics-and-healthy-controls-24140https://curecurrent.com/trials/effect-of-real-time-continuous-glucose-monitoring-system-on-the-management-of-type-2-diabetes-24141https://curecurrent.com/trials/management-of-patients-with-type-2-diabetes-and-hypertension-using-mobile-health-care-system-24142https://curecurrent.com/trials/paleolithic-diet-in-the-treatment-of-diabetes-type-2-in-primary-health-care-24143https://curecurrent.com/trials/the-acute-effect-of-atorvastain-on-renal-function-in-patients-with-type-ii-diabetes-24144https://curecurrent.com/trials/patients-with-heart-failure-and-type-2-diabetes-treated-with-placebo-or-metformin-phantom-pilot-study-24145https://curecurrent.com/trials/effects-of-copaxone-in-the-retinal-function-in-diabetic-patients-after-panphotocoagulation-24146https://curecurrent.com/trials/the-effect-of-broccoli-sprouts-as-a-nutritional-supplement-in-the-prevention-of-cardiovascular-disease-24147https://curecurrent.com/trials/corneal-endothelial-cell-loss-in-diabetes-type-ii-during-cataract-surgery-24148https://curecurrent.com/trials/effects-of-rosiglitazone-on-serum-ghrelin-and-peptide-yy-levels-24149https://curecurrent.com/trials/the-effect-of-renin-angiotensin-system-blockage-ras-blockade-on-ptx3-levels-in-diabetic-patients-with-proteinuria-24150https://curecurrent.com/trials/intravitreal-triamcinolone-acetonide-for-treatment-of-refractory-diffuse-diabetic-macular-edema-24151https://curecurrent.com/trials/testosterone-therapy-in-men-with-low-testosterone-levels-and-metabolic-syndrome-or-early-stages-of-type-2-diabetes-24152https://curecurrent.com/trials/high-dose-quinapril-versus-low-dose-quinapril-plus-amlodipine-in-the-treatment-of-high-risk-hypertensive-patients-24153https://curecurrent.com/trials/diffuse-diabetic-maculopathy-with-intravitreal-triamcinolone-or-laser-24154https://curecurrent.com/trials/vasoactive-hormones-and-oxygen-saturation-during-apneic-events-in-patients-with-obstructive-sleep-apnea-24155https://curecurrent.com/trials/assessment-of-the-effect-of-captopril-versus-combination-of-captopril-and-pentoxifylline-on-reducing-proteinuria-in-type-24156https://curecurrent.com/trials/diabetes-related-discrimination-at-workplace-and-by-insurances-24157https://curecurrent.com/trials/diabetic-neuropathy-topical-treatment-24158https://curecurrent.com/trials/dealing-with-anxiety-a-cognitive-behavioural-program-for-diabetes-24159https://curecurrent.com/trials/effects-of-losartan-on-myocardial-structure-in-diabetic-hypertensive-patients-with-left-ventricular-24160https://curecurrent.com/trials/effects-of-rosuvastatin-on-the-in-vivo-kinetic-of-apob-and-apoa1-using-stable-isotopes-in-type-2-diabetic-patients-24161https://curecurrent.com/trials/tight-glycemic-control-by-artificial-pancreas-24162https://curecurrent.com/trials/study-to-compare-intraperitoneal-insulin-to-subcutaneous-insulin-administration-in-type-1-diabetes-mellitus-24163https://curecurrent.com/trials/safety-and-efficacy-of-rt-cgms-in-patients-with-type-1-diabetes-mellitus-treated-with-an-implantable-pump-24164https://curecurrent.com/trials/ai-i-da-acarbose-and-the-subclinical-inflammation-24165https://curecurrent.com/trials/effect-of-nutritional-interventions-on-inflammatory-status-in-healthy-overweight-men-24166https://curecurrent.com/trials/self-operating-of-the-adi-insulin-pump-by-intended-users-a-usability-study-24167https://curecurrent.com/trials/prevention-of-clinical-onset-of-type-1-diabetes-in-high-risk-first-degree-relatives-24168https://curecurrent.com/trials/early-diagnosis-of-diabetes-mellitus-type-2-dm2-24169https://curecurrent.com/trials/efficacy-study-of-escitalopram-for-depression-in-patients-with-diabetes-24170https://curecurrent.com/trials/evaluation-of-the-effects-of-different-interventions-on-glycemic-control-in-newly-diagnosed-type-2-diabetic-patients-24171https://curecurrent.com/trials/bedtime-insulins-and-oral-antihyperglycemic-drugs-in-type-2-diabetes-24172https://curecurrent.com/trials/the-incidence-of-hypoglycemia-in-insulin-glargine-treated-subjects-with-diabetes-mellitus-upon-switching-between-bedtime-24173https://curecurrent.com/trials/continuous-glucose-monitoring-system-cgms-in-type-2-diabetic-patients-inadequately-controlled-by-metformine-monotherapy-24174https://curecurrent.com/trials/self-efficacy-enhancing-interviewing-techniques-study-24175https://curecurrent.com/trials/the-effects-of-nateglinide-and-acarbose-on-the-post-prandial-glucose-control-in-type-2-diabetic-patients-24176https://curecurrent.com/trials/safety-and-efficacy-of-iv-infusion-of-investigational-agent-tzp-101-in-patients-with-diabetic-gastroparesis-24177https://curecurrent.com/trials/insulin-sensitivity-of-the-brain-in-pathogenesis-of-diabetes-mellitus-type-2-24178https://curecurrent.com/trials/evaluation-of-the-glucotrack-non-invasive-glucose-monitoring-device-24179https://curecurrent.com/trials/gallant-7-tesaglitazar-add-on-to-sulphonylurea-24180https://curecurrent.com/trials/gallant-22-tesaglitazar-vs-placebo-24181https://curecurrent.com/trials/aramis-actions-of-tesaglitazar-on-fat-metabolism-and-insulin-sensitivity-24182https://curecurrent.com/trials/gallex-4-long-term-extension-study-to-evaluate-tesaglitazar-therapy-in-patients-with-type-2-diabetes-24183https://curecurrent.com/trials/gallant-4-tesaglitazar-vs-glibenclamide-24184https://curecurrent.com/trials/postprandial-fatty-acids-and-fabp2-in-type-2-diabetes-mellitus-dm-24185https://curecurrent.com/trials/nateglinide-a-double-blind-add-on-study-with-pioglitazone-for-type-2-diabetic-patients-24186https://curecurrent.com/trials/metabolic-syndrome-risk-factor-in-igt-stop-niddm-trial-24187https://curecurrent.com/trials/clinical-assessment-of-an-in-patient-glucose-monitoring-system-accu-chek-inform-cobas-it-1000-24188https://curecurrent.com/trials/mechanisms-responsible-for-cardiac-and-skeletal-muscle-energetic-impairment-in-diabetes-24189https://curecurrent.com/trials/do-you-need-to-assess-myocardial-ischemia-in-type-2-diabetes-24190https://curecurrent.com/trials/continuous-infusion-of-terlipressin-in-septic-shock-24191https://curecurrent.com/trials/beta-cell-transplantation-in-pre-uremic-patients-with-type-1-diabetes-24192https://curecurrent.com/trials/goal-life-style-change-intervention-to-prevent-type-2-diabetes-24193https://curecurrent.com/trials/near-normalisation-of-bg-improves-the-potentiating-effect-of-glp-1-24194https://curecurrent.com/trials/beta-cell-function-after-near-normalisation-of-blood-glucose-24195https://curecurrent.com/trials/pioglitazone-vs-insulin-glargine-in-the-treatment-of-secondary-drug-failure-in-type-2-diabetes-24196https://curecurrent.com/trials/safety-tolerability-and-activity-of-isis-113715-in-people-with-type-2-diabetes-mellitus-who-have-not-received-prior-trea-24197https://curecurrent.com/trials/tta-in-treatment-of-diabetes-and-dyslipidemia-24198https://curecurrent.com/trials/efficacy-and-safety-of-diamyd-in-children-and-adolescents-with-type-1-diabetes-24199https://curecurrent.com/trials/the-relationship-between-voiding-dysfunction-and-intravesical-sensory-threshold-in-diabetes-women-24200https://curecurrent.com/trials/magnesium-and-metabolic-syndrome-24201https://curecurrent.com/trials/yoga-for-treating-people-at-risk-for-diabetes-or-with-both-hiv-and-depression-24202https://curecurrent.com/trials/effect-of-pioglitazone-on-insulin-resistance-and-atherosclerosis-in-renal-allograft-recipients-without-diabetes-24203https://curecurrent.com/trials/effect-of-hyperglycemia-on-gastric-emptying-interactions-with-pramlintide-24204https://curecurrent.com/trials/flexible-intensive-insulin-therapy-in-patients-with-type-1-diabetes-24205https://curecurrent.com/trials/nippon-ultra-rapid-insulin-and-diabetic-complication-evaluation-study-nice-study-24206https://curecurrent.com/trials/safety-and-efficacy-of-as-3201-in-the-treatment-of-diabetic-sensorimotor-polyneuropathy-24207https://curecurrent.com/trials/bms-646256-in-obese-and-overweight-type-2-diabetics-24208https://curecurrent.com/trials/an-open-therapeutic-project-to-confirm-the-efficacy-tolerability-and-safety-profile-of-lantus-in-everyday-medical-practi-24209https://curecurrent.com/trials/extension-to-study-hmr1964a-3011-in-belgium-24210https://curecurrent.com/trials/randomized-trial-comparing-n-of-1-trials-to-standard-practice-to-improve-adherence-to-statins-in-patients-with-diabetes-24211https://curecurrent.com/trials/safety-and-efficacy-of-mcc-257-in-the-treatment-of-diabetic-polyneuropathy-24212https://curecurrent.com/trials/pharmaceutical-care-for-diabetes-type-2-patients-a-randomised-controlled-trial-24213https://curecurrent.com/trials/erectile-dysfunction-and-diabetes-mellitus-24214https://curecurrent.com/trials/study-evaluating-the-potential-of-dvs-sr-to-inhibit-the-cyp2d6-pathway-24215https://curecurrent.com/trials/metabolic-effects-of-pioglitazone-in-type-ii-diabetic-patients-previously-treated-with-insulin-24216https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-preliminary-efficacy-of-av411-in-neuropathic-pain-24217https://curecurrent.com/trials/evaluation-of-the-efficacy-of-rosuvastatin-in-daily-practice-in-untreated-high-risk-patients-challenge-24218https://curecurrent.com/trials/effects-of-cilostazol-on-plasma-adipocytokine-and-arterial-stiffness-24219https://curecurrent.com/trials/improving-blood-pressure-management-in-patients-with-diabetes-24220https://curecurrent.com/trials/capturing-outcomes-of-clinical-activities-performed-by-a-rounding-pharmacist-practising-in-a-team-environment-24221https://curecurrent.com/trials/n-acetylcysteine-and-arginine-administration-in-diabetic-patients-24222https://curecurrent.com/trials/study-evaluating-multiple-oral-doses-of-ppm-204-in-healthy-japanese-male-subjects-24223https://curecurrent.com/trials/basal-insulins-pharmacodynamics-24224https://curecurrent.com/trials/adipokines-as-predictors-of-the-metabolic-syndrome-in-all-survivors-24225https://curecurrent.com/trials/phase-iii-study-for-glimepiride-metformin-hydrochloride-amaryl-m-slow-release-sr-24226https://curecurrent.com/trials/effects-of-aliskiren-irbesartan-and-the-combination-in-hypertensive-patients-with-type-2-diabetes-and-diabetic-nephropat-24227https://curecurrent.com/trials/collection-of-blood-and-urine-specimens-from-volunteers-utilizing-health-examination-services-24228https://curecurrent.com/trials/how-does-early-age-life-style-affect-bone-strength-and-general-health-parameters-at-middle-age-24229https://curecurrent.com/trials/20-week-bridging-study-in-type-ii-dm-24230https://curecurrent.com/trials/effect-of-insulin-glulisine-vs-regular-human-insulin-on-postprandial-endothelial-function-in-type-2-diabetes-24231https://curecurrent.com/trials/adiponectin-in-obese-women-with-t2dn-and-effects-by-ras-blocker-24232https://curecurrent.com/trials/the-anti-diabetic-and-cholesterol-lowering-effects-of-cinnamon-and-cassia-bark-24233https://curecurrent.com/trials/study-of-vanadium-supplement-in-patients-with-impaired-glucose-tolerance-24234https://curecurrent.com/trials/pharmacogenetic-profiling-of-antipsychotics-induced-x-syndrome-and-diabetes-paxd-24235https://curecurrent.com/trials/the-effect-of-patients-participation-in-improving-diabetes-care-24236https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-daglutril-compared-to-placebo-on-top-of-losartan-in-type-2-diabetics-with-o-24237https://curecurrent.com/trials/efficacy-of-n-acetylcysteine-in-treatment-of-overt-diabetic-nephropathy-24238https://curecurrent.com/trials/long-term-effect-of-soy-consumption-on-cardio-renal-indices-and-crp-in-type-2diabetes-with-nephropathy-24239https://curecurrent.com/trials/abdominal-adipose-tissue-distribution-in-type-2-diabetic-patients-treated-during-6-months-with-pioglitazone-or-insulin-24240https://curecurrent.com/trials/higher-dose-of-ramipril-versus-addition-of-telmisartan-ramipril-in-hypertension-and-diabetes-24241https://curecurrent.com/trials/leptin-and-cytokines-in-diabetic-pregnancy-physiologic-or-pathogenic-role-24242https://curecurrent.com/trials/assessment-of-duration-of-metabolic-effect-of-a-single-bolus-of-sc-injected-lantus-compared-to-nph-insulin-in-patients-w-24243https://curecurrent.com/trials/the-effects-of-tirofiban-in-diabetic-patients-undergoing-elective-percutaneous-coronary-intervention-24244https://curecurrent.com/trials/effect-of-continuous-glucose-monitoring-on-course-of-glucose-in-type-1-diabetes-24245https://curecurrent.com/trials/lispro-mix-25-vs-glargine-in-type-2-diabetics-24246https://curecurrent.com/trials/the-effect-of-glp-1-on-glucose-uptake-in-the-brain-and-heart-in-healthy-men-24247https://curecurrent.com/trials/irbesartan-effects-on-endothelial-dysfunction-in-hypertensive-type-ii-diabetic-patients-comparing-atenolol-24248https://curecurrent.com/trials/20-versus-23-gauge-system-for-pars-plana-vitrectomy-24249https://curecurrent.com/trials/intensive-medical-treatment-for-nephropathy-caused-by-type-2-diabetes-with-hypertension-24250https://curecurrent.com/trials/effect-of-pioglitazone-therapy-for-type-2-diabetes-on-vision-24251https://curecurrent.com/trials/study-the-safety-and-effectiveness-of-tadalafil-in-men-with-diabetes-who-have-problems-getting-and-keeping-an-erection-24252https://curecurrent.com/trials/blood-glucose-response-to-meals-of-varying-glycemic-index-in-youth-with-type-1-2-diabetes-24253https://curecurrent.com/trials/an-intervention-program-to-control-diabetes-24254https://curecurrent.com/trials/effect-of-beta-blocker-treatment-on-endothelial-function-in-patients-with-type-2-diabetes-or-chronic-heart-failure-24255https://curecurrent.com/trials/type-2-diabetes-patients-switched-from-sulfonylurea-with-metformin-to-glyburide-metformin-combination-tablet-24256https://curecurrent.com/trials/peripheral-and-coronary-endothelial-dysfunction-in-type-2diabetic-patients-role-of-metformin-24257https://curecurrent.com/trials/nephrodiab2-prospective-randomized-controlled-open-labelled-trial-comparing-effect-of-two-haemoglobin-levels-24258https://curecurrent.com/trials/32-week-open-randomized-2-way-cross-over-multicentre-trial-to-compare-safety-efficacy-of-combination-of-hoe901-insulin-a-24259https://curecurrent.com/trials/chronic-treatment-with-benfotiamine-restores-endothelial-function-in-people-with-type-2-diabetes-mellitus-24260https://curecurrent.com/trials/metabolic-profile-and-anthropometric-changes-in-schizophrenia-24261https://curecurrent.com/trials/investigation-of-genetic-risk-of-metabolic-syndrome-in-company-employee-ngk-study-24262https://curecurrent.com/trials/dietary-interventions-in-type-2-obese-diabetic-patients-in-the-community-24263https://curecurrent.com/trials/lancgms-lantus-continuous-glucose-monitoring-subcutaneous-24264https://curecurrent.com/trials/acute-effects-of-sildenafil-on-endothelial-function-in-people-with-diabetes-24265https://curecurrent.com/trials/telemedicine-influence-in-the-follow-up-of-the-type-2-diabetes-patient-24266https://curecurrent.com/trials/effect-of-intravitreal-bevacizumab-on-early-post-vitrectomy-hemorrhage-in-diabetic-patients-24267https://curecurrent.com/trials/body-composition-bone-mineral-density-insulin-sensitivity-and-echocardiographic-measurements-in-klinefelter-syndrome-24268https://curecurrent.com/trials/fenofibrate-in-dyslipidemia-and-metformin-controlled-diabetes-24269https://curecurrent.com/trials/acceptability-study-of-a-new-fixed-combination-of-fenofibrate-80-mg-bid-and-metformin-1000-mg-bid-in-type-2-diabetes-and-24270https://curecurrent.com/trials/acceptability-of-a-fixed-combination-of-fenofibrate-and-metformin-24271https://curecurrent.com/trials/comparison-of-insulin-glargine-and-nph-insulin-at-night-and-at-hypoglycemia-in-type-2-diabetes-24272https://curecurrent.com/trials/effects-of-achieving-very-low-ldl-cholesterol-after-treatment-with-statins-on-steroidogenesis-and-cognition-24273https://curecurrent.com/trials/c-reactive-protein-crp-in-obese-diabetic-women-24274https://curecurrent.com/trials/screening-for-undiagnosed-type-2-diabetes-in-new-classes-of-subjects-at-high-risk-24275https://curecurrent.com/trials/inflammatory-response-and-pregnancy-outcome-in-women-with-type-2-diabetes-or-overweight-24276https://curecurrent.com/trials/safety-and-efficacy-of-pregabalin-in-patients-with-diabetic-peripheral-neuropathy-24277https://curecurrent.com/trials/wound-healing-effects-of-ho-03-03-in-patients-with-diabetic-neuropathic-plantar-and-venous-ulcers-pilot-study-24278https://curecurrent.com/trials/metabolic-effect-of-insulin-aspart-and-human-insulin-in-different-doses-24279https://curecurrent.com/trials/lyspro-insulin-vs-regular-insulin-in-cirrhotic-patients-24280https://curecurrent.com/trials/apligraf-versus-standard-therapy-in-the-treatment-of-diabetic-foot-ulcers-24281https://curecurrent.com/trials/diabetic-retinopathy-and-diabetic-macular-edema-screening-by-non-physicians-with-limited-training-24282https://curecurrent.com/trials/high-dose-ace-inhibitor-therapy-versus-combination-of-ace-and-arb-therapy-24283https://curecurrent.com/trials/effect-of-adiponectin-genetic-polymorphism-on-rosiglitazone-response-24284https://curecurrent.com/trials/testing-ascensia-contour-glucometer-for-the-measurement-of-blood-glucose-24285https://curecurrent.com/trials/lifestyle-intervention-in-primary-health-care-the-bj-rkn-s-study-24286https://curecurrent.com/trials/effect-of-coccinia-cordifolia-extract-on-blood-sugar-of-newly-diagnosed-diabetics-24287https://curecurrent.com/trials/penetration-of-ertapenem-into-bone-24288https://curecurrent.com/trials/investigation-of-correlation-between-concentrations-of-glucose-in-blood-and-interstitial-fluid-in-type-1-diabetics-24289https://curecurrent.com/trials/duodenal-jejunal-bypass-for-type-2-diabetes-djbd-24290https://curecurrent.com/trials/association-between-rosiglitazone-use-and-clinical-course-of-diabetic-nephropathy-population-based-study-24291https://curecurrent.com/trials/to-compare-the-efficacy-and-safey-of-vildagliptin-compared-to-voglibose-in-patients-with-type-2-diabetes-24292https://curecurrent.com/trials/a-one-year-randomized-double-blind-placebo-controlled-trial-of-rosiglitazone-in-non-alcoholic-steatohepatitis-24293https://curecurrent.com/trials/the-role-of-physical-activity-in-the-treatment-of-children-with-type-1-diabetes-24294https://curecurrent.com/trials/clinical-study-of-the-effect-of-intravenous-galactose-on-diabetic-macular-oedema-24295https://curecurrent.com/trials/hypoglycemia-counterregulation-and-symptom-perception-with-insulin-detemir-24296https://curecurrent.com/trials/comprehensive-management-of-diabetic-patients-with-renal-impairment-impact-on-blood-pressure-and-glycemic-control-24297https://curecurrent.com/trials/chicken-diet-vs-enalapril-to-reduce-albuminuria-24298https://curecurrent.com/trials/comparison-between-pioglitazone-and-ses-with-type2-dm-24299https://curecurrent.com/trials/the-effects-of-vacuum-compression-therapy-on-the-healing-of-diabetic-foot-ulcers-24300https://curecurrent.com/trials/hepatocyte-growth-factor-and-cardiovascular-autonomic-function-24301https://curecurrent.com/trials/intravitreal-triamcinolone-acetonide-for-diabetic-macular-edema-24302https://curecurrent.com/trials/hyperbaric-oxygen-therapy-and-angiogenesis-in-diabetic-patients-with-foot-ulcers-24303https://curecurrent.com/trials/impact-of-optimized-titration-and-delivery-of-bedtime-insulin-on-prevention-of-nocturnal-hypoglycemia-24304https://curecurrent.com/trials/glucagon-like-peptides-receptors-expression-in-the-stomach-of-diabetes-type-2-24305https://curecurrent.com/trials/do-sulphonylureas-preserve-cortical-function-during-hypoglycaemia-24306https://curecurrent.com/trials/clinical-factors-associated-floppy-iris-24307https://curecurrent.com/trials/to-assess-the-efficacy-and-safety-of-vildagliptin-as-add-on-therapy-to-sulfonylurea-in-patients-with-type-2-diabetes-ina-24308https://curecurrent.com/trials/the-effects-of-exercise-on-adipokine-in-impaired-fasting-glucose-or-impaired-glucose-tolerance-patients-24309https://curecurrent.com/trials/simvastatin-reduces-circulating-osteoprotegerin-levels-in-patients-with-type-2-diabetes-24310https://curecurrent.com/trials/doxazosin-effects-on-abpm-in-hypertensive-patients-with-diabetic-nephropathy-24311https://curecurrent.com/trials/diabetes-quality-improvement-program-on-diabetes-case-management-program-2001-24312https://curecurrent.com/trials/cards-is-designed-to-show-if-lowering-cholesterol-with-atorvastatin-in-type-2-diabetics-without-cv-disease-reduces-the-r-24313https://curecurrent.com/trials/a-study-to-compare-the-effect-of-vildagliptin-compared-to-placebo-in-patients-with-type-2-diabetes-24314https://curecurrent.com/trials/autonomic-imbalance-and-24-h-blood-pressure-change-in-patients-with-chronic-renal-disease-24315https://curecurrent.com/trials/the-effect-of-licorice-root-extract-and-pomegranate-juice-on-atherosclerotic-parameters-in-diabetic-patients-24316https://curecurrent.com/trials/intravitreal-triamcinolone-acetonide-versus-intravitreal-bevacizumab-for-refractory-diabetic-macular-edema-ibeme-study-24317https://curecurrent.com/trials/hospital-in-patient-insulin-study-24318https://curecurrent.com/trials/sub-cutaneous-insulin-in-hyperglycaemic-emergencies-24319https://curecurrent.com/trials/optimal-dietary-fat-pattern-to-prevent-cardiovascular-disease-among-type-2-diabetes-24320https://curecurrent.com/trials/autologous-bone-marrow-mononuclear-cells-transplantation-in-treating-diabetes-patients-24321https://curecurrent.com/trials/bioavailability-of-insulin-administered-in-duodenum-24322https://curecurrent.com/trials/japan-early-diabetes-intervention-study-24323https://curecurrent.com/trials/glucose-control-with-multiple-daily-insulin-injections-in-diabetic-patients-hospitalized-in-a-general-medicine-ward-24324https://curecurrent.com/trials/the-effect-of-metformin-treatment-on-thyroid-hormone-metabolism-in-euthyroid-patients-with-type-2-diabetes-mellitus-24325https://curecurrent.com/trials/physical-activity-insulin-resistance-and-function-of-fat-tissue-in-the-offspring-of-patients-with-type-2-diabetes-24326https://curecurrent.com/trials/mol-share-molecular-study-of-health-assessment-and-risk-in-ethnic-groups-24327https://curecurrent.com/trials/comparison-between-insulin-pump-treatment-and-multiple-daily-insulin-injections-in-diabetic-type-1-children-24328https://curecurrent.com/trials/efficacy-and-safety-of-berberine-in-the-treatment-of-diabetes-with-dyslipidemia-24329https://curecurrent.com/trials/effect-of-urtica-dioica-on-glycemic-control-in-patients-with-type-2-diabetes-mellitus-24330https://curecurrent.com/trials/ischemic-injury-and-ischemic-preconditioning-in-diabetes-24331https://curecurrent.com/trials/developement-of-questionnaire-to-evaluate-a-regularity-of-lifestyle-in-type-2-diabetic-patients-24332https://curecurrent.com/trials/rosiglitazone-and-exercise-in-patients-with-type-2-diabetes-mellitus-24333https://curecurrent.com/trials/influence-of-physical-training-on-mitochondrial-function-in-type-2-diabetic-patients-24334https://curecurrent.com/trials/loadd-lifestyle-over-and-above-drugs-in-diabetes-study-24335https://curecurrent.com/trials/prospective-study-of-patients-with-hirsutism-24336https://curecurrent.com/trials/in-hospital-hyperglycemia-effects-of-treatment-on-glycemic-control-and-clinical-outcome-24337https://curecurrent.com/trials/safety-and-efficacy-of-using-glucosat-technology-for-non-invasive-glucose-measurement-24338https://curecurrent.com/trials/prevalence-of-macrovascular-disease-in-type-2-diabetes-mellitus-24339https://curecurrent.com/trials/effect-of-low-protein-diet-in-preventing-the-progression-of-diabetic-nephropathy-24340https://curecurrent.com/trials/microvascular-response-in-diabetes-mellitus-24341https://curecurrent.com/trials/intravitreal-bevacizumab-for-proliferative-diabetic-retinopathy-24342https://curecurrent.com/trials/structured-patient-education-and-quality-of-life-of-elderly-patients-with-diabetes-mellitus-a-prospective-study-24343https://curecurrent.com/trials/triamcinolone-as-adjunctive-treatment-to-laser-panretinal-photocoagulation-for-proliferative-diabetic-retinopathy-24344https://curecurrent.com/trials/prediction-of-nodat-after-renal-transplantation-24345https://curecurrent.com/trials/effect-of-acute-psychological-stress-on-glucose-concentrations-in-patients-with-type-2-diabetes-24346https://curecurrent.com/trials/incidence-of-cardiovascular-diseases-in-patients-with-hypopituitarims-24347https://curecurrent.com/trials/treatment-of-patients-with-type-2-diabetes-with-an-interleukin-1-antagonist-24348https://curecurrent.com/trials/prevention-of-cardiovascular-complications-in-diabetic-patients-with-vitamin-e-treatment-24349https://curecurrent.com/trials/flexible-intensive-vs-conventional-insulin-therapy-in-insulin-naive-adults-with-type-2-diabetes-24350https://curecurrent.com/trials/effects-of-rosiglitazone-on-bone-in-postmenopausal-diabetic-women-24351https://curecurrent.com/trials/aceis-and-arbs-treatment-in-diabetic-patients-drug-interactions-and-adverse-drug-effects-24352https://curecurrent.com/trials/effects-of-benfotiamine-and-age-on-endothelial-function-in-people-with-diabetes-24353https://curecurrent.com/trials/diabetic-patients-with-end-stage-renal-disease-24354https://curecurrent.com/trials/severe-hypoglycemia-in-pregnant-women-with-type-1-diabetes-24355https://curecurrent.com/trials/ezetimibe-and-simvastatin-in-dyslipidemia-of-diabetes-24356https://curecurrent.com/trials/a-study-evaluating-the-effects-of-lipid-lowering-treatment-on-steroid-synthesis-24357https://curecurrent.com/trials/aspirin-and-enalapril-in-microalbuminuric-type-2-diabetes-mellitus-patients-24358https://curecurrent.com/trials/therapeutic-effects-of-berberine-in-patients-with-type-2-diabetes-24359https://curecurrent.com/trials/effect-of-electroacupuncture-in-diabetic-patients-with-gastroparesis-24360https://curecurrent.com/trials/effect-of-chronic-pde5-inhibition-on-endothelial-function-in-diabetics-24361https://curecurrent.com/trials/polyclonal-anti-t-lymphocyte-globulin-atg-in-type-1-diabetes-24362https://curecurrent.com/trials/the-potential-effects-and-mechanisms-of-flax-lignans-on-type-2-diabetes-mellitus-24363https://curecurrent.com/trials/effect-of-pioglitazone-on-cardiovascular-outcome-on-higashi-saitama-trial-in-patients-with-type-2-diabetes-24364https://curecurrent.com/trials/additional-glucose-lowering-and-anti-inflammatory-effects-by-acarbose-and-alcohol-in-subjects-with-impaired-glucose-tole-24365https://curecurrent.com/trials/to-evaluate-the-safety-and-efficacy-of-pregabalin-in-patients-with-painful-diabetic-peripheral-neuropathy-24366https://curecurrent.com/trials/evaluation-of-effect-of-exercise-on-prescription-24367https://curecurrent.com/trials/metformin-for-the-treatment-of-diabetes-in-pregnancy-24368https://curecurrent.com/trials/type-2-diabetes-and-the-effect-of-probiotics-24369https://curecurrent.com/trials/study-of-renal-blood-flow-during-human-endotoxemia-24370https://curecurrent.com/trials/clinical-and-angiographic-outcomes-with-hyperglycemic-control-post-pci-24371https://curecurrent.com/trials/effect-of-mobile-communication-with-a-cellular-phone-with-a-glucometer-on-glucose-control-in-type-2-diabetic-patients-24372https://curecurrent.com/trials/the-gene-expression-patterns-in-the-peripheral-white-blood-cells-of-type-2-diabetic-patients-24373https://curecurrent.com/trials/comparison-of-sirolimus-alone-with-sirolimus-plus-tacrolimus-in-type-1-diabetic-recipients-of-cultured-islet-cell-grafts-24374https://curecurrent.com/trials/sulfonylurea-response-in-patients-with-diabetes-due-to-kir6-2-mutations-24375https://curecurrent.com/trials/maximal-dose-of-angiotensin-converting-enzyme-ace-inhibitor-for-treatment-of-diabetic-kidney-disease-24376https://curecurrent.com/trials/dietary-fish-protein-in-subjects-with-insulin-resistance-24377https://curecurrent.com/trials/efficacy-of-a-low-molecular-weight-heparin-bemiparin-in-the-treatment-of-chronic-foot-ulcers-in-diabetic-patients-24378https://curecurrent.com/trials/double-blind-randomized-trial-to-compare-gurmar-gymnema-sylvestre-with-metformin-in-type-2-diabetes-24379https://curecurrent.com/trials/the-diabetes-specialist-nurse-as-delegated-main-care-provider-for-patients-with-type-2-diabetes-24380https://curecurrent.com/trials/safety-efficacy-of-a-combination-niacin-er-simvastatin-in-patients-with-dyslipidemia-a-dose-ranging-study-seacoast-24381https://curecurrent.com/trials/comparative-efficacy-evaluation-of-lipids-when-treated-with-niaspan-statin-or-other-lipid-modifying-therapies-compell-24382https://curecurrent.com/trials/matched-mc-1-and-ace-therapeutic-combination-for-hypertensive-diabetics-24383https://curecurrent.com/trials/sgs-a-structured-treatment-and-teaching-programme-for-elderly-patients-with-diabetes-mellitus-24384https://curecurrent.com/trials/an-rct-to-evaluate-incidence-cost-and-clinical-outcomes-using-75-vs-100g-screening-methods-for-gestational-diabetes-24385https://curecurrent.com/trials/efficacy-of-soluble-beta-1-3-1-6-glucan-compared-to-placebo-on-chronic-leg-ulcers-in-diabetes-patients-24386https://curecurrent.com/trials/multiple-grain-in-type-2-diabetes-24387https://curecurrent.com/trials/anticipatory-preventive-team-care-aptcare-at-risk-patients-of-family-health-networks-24388https://curecurrent.com/trials/insulin-novorapid-versus-actrapid-in-treatment-of-type-1-diabetic-patients-during-daily-adjustment-of-insulin-dose-24389https://curecurrent.com/trials/olmesartan-medoxomil-and-diabetic-nephropathy-24390https://curecurrent.com/trials/effects-of-miglitol-on-daily-plasma-glucose-in-type2-diabetes-treated-with-insulin-24391https://curecurrent.com/trials/double-blind-study-of-miglitol-in-japanese-with-type2-diabetes-24392https://curecurrent.com/trials/study-of-improving-insulin-sensitivity-by-electroacupuncture-therapy-24393https://curecurrent.com/trials/double-blind-trial-of-miglitol-in-type-2-diabetic-patients-with-insulin-treatment-24394https://curecurrent.com/trials/open-trial-of-miglitol-in-type-1-diabetic-patients-with-insulin-treatment-24395https://curecurrent.com/trials/intranasal-insulin-for-prevention-of-type-1-diabetes-24396https://curecurrent.com/trials/the-home-trial-hyperinsulinaemia-the-outcome-of-its-metabolic-effects-a-randomized-controlled-trial-24397https://curecurrent.com/trials/the-effects-of-two-education-strategies-about-insulin-on-patient-preferences-and-perceptions-about-insulin-therapy-24398https://curecurrent.com/trials/integrating-family-medicine-and-pharmacy-to-advance-primary-care-therapeutics-24399https://curecurrent.com/trials/study-protocol-for-rosiglitazone-versus-gliclazide-in-diabetics-with-angina-24400https://curecurrent.com/trials/rosiglitazone-and-insulin-in-t1dm-adolescents-24401https://curecurrent.com/trials/effect-of-fish-oil-on-adiposity-and-atherogenic-factors-in-type-2-diabetic-women-24402https://curecurrent.com/trials/early-treatment-diabetic-retinopathy-study-etdrs-24403https://curecurrent.com/trials/jikei-optimal-insulin-therapy-in-type-2-diabetes-24404https://curecurrent.com/trials/efficacy-and-safety-of-atl-962-in-obese-diabetics-24405https://curecurrent.com/trials/dose-exposure-response-in-type-1-diabetes-mellitus-24406https://curecurrent.com/trials/moderate-alcohol-consumption-risk-of-cardiovascular-disease-and-type-2-diabetes-influence-of-alcohol-oxidation-24407https://curecurrent.com/trials/observational-study-of-changes-in-fat-distribution-and-blood-metabolites-in-hiv-infected-adults-24408https://curecurrent.com/trials/effect-of-chia-seeds-salvia-hispanica-l-on-glucose-control-in-patients-with-type-2-diabetes-24409https://curecurrent.com/trials/a-comparison-of-pharmacodynamics-and-pharmacokinetics-of-insulin-aspart-biphasic-insulin-aspart-30-50-and-70-24410https://curecurrent.com/trials/prevention-of-severe-hypoglycemia-in-type-1-diabetes-24411https://curecurrent.com/trials/effects-of-losartan-on-insulin-sensitivity-and-secretion-in-type-2-diabetes-and-nephropathy-24412https://curecurrent.com/trials/cbt-in-adolescents-with-type-1-diabetes-24413https://curecurrent.com/trials/local-registration-trial-in-china-humalog-mix-50-24414https://curecurrent.com/trials/a-study-on-ca-blocker-versus-aii-antagonists-in-hypertension-with-type-2-diabetes-24415https://curecurrent.com/trials/web-based-follow-up-using-cellular-phone-in-type-1-diabetic-patients-under-insulin-pump-therapy-the-pumpnet-study-24416https://curecurrent.com/trials/efficacy-pilot-study-of-triflusal-in-the-attenuation-of-insulin-resistance-in-human-obesity-24417https://curecurrent.com/trials/electromagnetic-stimulation-frems-in-patients-with-painful-diabetic-neuropathy-24418https://curecurrent.com/trials/a-double-blind-randomized-parallel-comparative-study-to-evaluate-the-efficacy-and-safety-of-an-antidiabetic-agent-repagl-24419https://curecurrent.com/trials/diabetic-retinopathy-study-drs-24420https://curecurrent.com/trials/hypertension-related-damage-to-the-microcirculation-in-south-asian-emergence-predictive-power-and-reversibility-24421https://curecurrent.com/trials/comparison-of-vasopressin-and-other-pressors-in-septic-shock-24422https://curecurrent.com/trials/population-based-strategies-for-effective-control-of-high-blood-pressure-in-pakistan-24423https://curecurrent.com/trials/diabetes-type-1-treatment-study-atacand-placebo-after-kidney-biopsy-24424https://curecurrent.com/trials/optimal-dose-of-irbesartan-for-renoprotection-in-type-2-diabetic-patients-with-persistent-microalbuminuria-24425https://curecurrent.com/trials/trial-of-motivational-interviewing-in-adolescents-with-diabetes-24426https://curecurrent.com/trials/efficacy-and-safety-of-nateglinide-treatment-in-renal-transplant-recipients-24427https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-vitamin-d-supplementation-on-insulin-sensitivity-and-secretion-24428https://curecurrent.com/trials/effect-of-pyridorin-in-patients-with-diabetic-nephropathy-24429https://curecurrent.com/trials/effect-of-pyridorin-in-patients-with-diabetic-nephropathy-24430https://curecurrent.com/trials/rationale-and-design-for-shiga-microalbuminuria-reduction-trial-24431https://curecurrent.com/trials/spironolactone-in-diabetic-nephropathy-24432https://curecurrent.com/trials/irbesartan-in-type-2-diabetes-24433https://curecurrent.com/trials/long-term-effects-of-sucontral-tm-on-mild-and-moderate-cases-of-diabetes-mellitus-type-2-24434https://curecurrent.com/trials/renoprotective-effect-of-nisoldipine-and-lisinopril-in-type-1-diabetic-nephropathy-24435https://curecurrent.com/trials/instrument-development-of-screening-prediabetes-patients-24436https://curecurrent.com/trials/the-prevalence-of-metabolic-syndrome-and-its-associated-factors-in-an-urban-city-24437https://curecurrent.com/trials/pancreatic-islet-function-insulin-sensitivity-and-chronic-complications-in-pre-diabetes-24438https://curecurrent.com/trials/wound-healing-total-contact-cast-vs-custom-made-temporary-footwear-for-patients-with-diabetic-foot-ulceration-24439https://curecurrent.com/trials/effects-of-rosiglitazone-on-plasma-bnp-levels-and-left-ventricular-dysfunction-24440https://curecurrent.com/trials/non-insulin-dependent-diabetes-mellitus-niddm-and-angiotensin-converting-enzyme-2-ace2-diabetic-patients-treated-with-an-24441https://curecurrent.com/trials/study-of-novel-types-of-familial-diabetes-insipidus-24442https://curecurrent.com/trials/which-needle-length-for-injecting-insulin-24443https://curecurrent.com/trials/ambulatory-blood-pressure-reduction-after-rosiglitazone-treatment-in-normotensive-type-2-diabetic-patients-24444https://curecurrent.com/trials/efficacy-and-safety-study-of-chromium-picolinate-biotin-on-glucose-and-cholesterol-control-in-t2dm-24445https://curecurrent.com/trials/effect-of-metabolic-therapy-in-patients-with-chronic-ischemic-heart-disease-24446https://curecurrent.com/trials/life-style-modifications-prevents-type-2-diabetes-in-asian-indians-24447https://curecurrent.com/trials/effect-of-c-peptide-on-diabetic-peripheral-neuropathy-24448https://curecurrent.com/trials/study-of-glucose-in-dialysis-water-with-regard-to-blood-pressure-and-quality-of-life-24449https://curecurrent.com/trials/change-of-lifestyle-by-persons-in-risk-of-type-2-diabetes-24450https://curecurrent.com/trials/autoantibodies-in-patients-with-type-1-diabetes-mellitus-24451https://curecurrent.com/trials/diagnosis-of-insulin-resistance-13c-glucose-breath-test-vs-homa-index-24452https://curecurrent.com/trials/characterizing-and-diagnosis-s-of-the-charcot-foot-charcot-osteoarthropathy-in-diabetic-patients-24453https://curecurrent.com/trials/association-of-colorectal-cancer-with-nutrition-diet-obesity-diabetes-mellitus-and-genetic-alterations-in-taiwan-24454https://curecurrent.com/trials/changes-in-skin-innervation-of-neurologically-asymptomatic-type-2-diabetic-patients-the-correlation-with-the-diabetic-pa-24455https://curecurrent.com/trials/the-role-of-regulatory-t-cell-in-patients-with-type-1-diabetes-mellitus-24456https://curecurrent.com/trials/effects-of-chromium-supplementation-on-parameters-of-the-metabolic-syndrome-in-patients-with-type-2-diabetes-mellitus-24457https://curecurrent.com/trials/a-study-on-effect-of-health-promotion-for-prevention-niddm-in-people-with-prediabetes-24458https://curecurrent.com/trials/use-of-a-portion-control-food-tool-to-induce-weight-loss-in-obese-type-2-diabetics-24459https://curecurrent.com/trials/substitution-of-first-phase-insulin-response-in-patient-with-type-2-diabetes-24460https://curecurrent.com/trials/intervention-to-preserve-beta-cell-function-in-gad-ab-positive-diabetes-24461https://curecurrent.com/trials/japanese-primary-prevention-project-with-aspirin-24462https://curecurrent.com/trials/prevalence-of-diabetes-mellitus-among-patients-treated-with-atypical-and-conventional-antipsychotics-24463https://curecurrent.com/trials/canadian-trial-of-dietary-carbohydrates-in-diabetes-24464https://curecurrent.com/trials/he-purongo-mo-nga-kai-hei-arai-i-te-matehuka-dietary-diabetes-prevention-study-for-maori-24465https://curecurrent.com/trials/measures-of-obesity-and-co-morbid-conditions-in-maori-24466https://curecurrent.com/trials/promoting-blood-pressure-control-and-cholesterol-reduction-to-prevent-major-complications-in-persons-with-diabetes-24467https://curecurrent.com/trials/efficacy-of-2-diet-plans-designed-for-people-with-type-ii-diabetes-on-weight-and-health-measures-24468https://curecurrent.com/trials/evaluation-of-continuity-of-care-at-a-health-service-organization-24469https://curecurrent.com/trials/diabetes-prevention-program-in-schizophrenia-dpps-24470https://curecurrent.com/trials/the-relation-between-serum-level-of-amioterminal-propeptide-of-type-i-procollagen-and-diastolic-dysfunction-in-hypertens-24471https://curecurrent.com/trials/the-prevalence-of-erectile-dysfunction-ed-and-ed-related-quality-of-life-of-diabetic-men-24472https://curecurrent.com/trials/patient-provider-partnership-improving-diabetes-care-in-the-community-24473https://curecurrent.com/trials/a-study-of-two-versus-three-daily-injections-in-children-and-adolescents-with-newly-diagnosed-type-1-diabetes-24474https://curecurrent.com/trials/multifactorial-intervention-on-cardiovascular-risk-factors-in-subjects-with-peripheral-arterial-disease-24475https://curecurrent.com/trials/atorvastatin-and-endothelial-function-in-type-2-diabetes-mellitus-attend-study-24476https://curecurrent.com/trials/rosiglitazone-plaque-study-24477https://curecurrent.com/trials/using-the-drug-spironolactone-to-test-if-it-reduces-protein-leakage-from-the-kidney-24478https://curecurrent.com/trials/krypton-argon-regression-of-neovascularization-study-karns-24479https://curecurrent.com/trials/study-of-genotype-and-phenotype-expression-in-congenital-nephrogenic-diabetes-insipidus-24480https://curecurrent.com/trials/diabetic-retinopathy-vitrectomy-study-drvs-24481https://curecurrent.com/trials/an-open-label-extension-study-of-ngx-4010-for-the-treatment-of-neuropathic-pain-24482https://curecurrent.com/trials/does-islet-transplantation-eliminate-hypoglycemia-24483https://curecurrent.com/trials/identification-and-therapy-efficacy-of-type-2-diabetes-in-hispanic-patients-24484https://curecurrent.com/trials/sorbinil-retinopathy-trial-srt-24485https://curecurrent.com/trials/phase-iii-randomized-double-blind-placebo-controlled-study-of-mexiletine-for-painful-diabetic-neuropathy-24486https://curecurrent.com/trials/stereotactic-body-radiation-therapy-and-fes-pet-ct-imaging-for-the-treatment-of-oligoprogressive-estrogen-receptor-posit-24487https://curecurrent.com/trials/smp-3124lp-in-adults-with-advanced-solid-tumors-24488https://curecurrent.com/trials/collection-of-csf-samples-from-participants-with-metastatic-triple-negative-breast-cancer-tnbc-and-her2-breast-cancer-wi-24489https://curecurrent.com/trials/paclitaxel-carboplatin-durvalumab-with-or-without-oleclumab-for-previously-untreated-locally-recurrent-inoperable-or-met-24490https://curecurrent.com/trials/impact-of-covid-19-pandemic-on-out-of-pocket-costs-lost-wages-and-unemployment-in-patients-with-breast-cancer-undergoing-24491https://curecurrent.com/trials/testing-whether-hormone-therapy-with-ribociclib-is-as-effective-as-chemotherapy-followed-by-hormone-therapy-with-ribocic-24492https://curecurrent.com/trials/phase-iiib-study-of-ribociclib-et-in-early-breast-cancer-24493https://curecurrent.com/trials/neo-adjuvant-chemotherapy-combined-with-stereotactic-body-radiotherapy-to-the-primary-tumour-durvalumab-oleclumab-in-lum-24494https://curecurrent.com/trials/ds-8201a-versus-t-dm1-for-human-epidermal-growth-factor-receptor-2-her2-positive-unresectable-and-or-metastatic-breast-c-24495https://curecurrent.com/trials/low-field-mri-for-breast-cancer-screening-24496https://curecurrent.com/trials/surgical-excision-vs-neoadjuvant-radiotherapy-delayed-surgical-excision-of-ductal-carcinoma-24497https://curecurrent.com/trials/a-study-of-sofe-m-in-participants-with-selected-advanced-solid-tumors-24498https://curecurrent.com/trials/natural-history-study-of-early-life-exposures-in-agriculture-elea-24499https://curecurrent.com/trials/3d-printed-breast-models-in-the-surgical-management-of-breast-cancer-24500https://curecurrent.com/trials/negative-pressure-wound-therapy-in-healing-abdominal-incision-in-obese-patients-undergoing-breast-reconstruction-surgery-24501https://curecurrent.com/trials/18f-flt-pet-ct-in-rb-metastatic-breast-cancer-24502https://curecurrent.com/trials/relaxation-for-women-with-breast-cancer-undergoing-radiotherapy-24503https://curecurrent.com/trials/dna-guided-second-line-adjuvant-therapy-for-high-residual-risk-estrogen-receptor-positive-her-2-negative-breast-cancer-d-24504https://curecurrent.com/trials/identifying-decision-making-needs-for-older-adult-women-with-stage-i-iii-breast-cancer-considering-neoadjuvant-or-adjuva-24505https://curecurrent.com/trials/metastasis-directed-therapy-for-oligometastases-of-breast-cancer-24506https://curecurrent.com/trials/us-pa-e-imaging-for-early-identification-of-tumor-response-in-patients-with-stage-ii-iii-triple-negative-breast-cancer-r-24507https://curecurrent.com/trials/dce-mri-and-mbi-in-assessing-tumor-response-to-chemotherapy-in-patients-with-triple-negative-breast-cancer-24508https://curecurrent.com/trials/tao-towards-optimal-neo-adjuvant-systemic-therapy-of-stage-iii-triple-negative-breast-cancer-24509https://curecurrent.com/trials/adding-an-immunotherapy-drug-medi4736-durvalumab-to-the-usual-chemotherapy-treatment-paclitaxel-cyclophosphamide-and-dox-24510https://curecurrent.com/trials/incentive-spirometry-with-and-without-transcutaneous-electric-diaphragmatic-stimulation-in-post-mastectomy-patients-24511https://curecurrent.com/trials/exercise-fitness-and-tumor-profiling-in-breast-cancer-patients-24512https://curecurrent.com/trials/targeted-therapy-directed-by-genetic-testing-in-treating-patients-with-locally-advanced-or-advanced-solid-tumors-the-com-24513https://curecurrent.com/trials/elacestrant-for-treating-er-her2-breast-cancer-patients-with-ctdna-relapse-treat-ctdna-24514https://curecurrent.com/trials/partial-breast-irradiation-pbi-using-40-gy-for-select-patients-with-early-invasive-or-noninvasive-breast-cancer-24515https://curecurrent.com/trials/testing-the-effects-of-palbociclib-and-fulvestrant-or-letrozole-for-patients-70-years-of-age-of-older-with-metastatic-br-24516https://curecurrent.com/trials/the-hurria-older-patients-hope-with-breast-cancer-study-24517https://curecurrent.com/trials/the-impact-of-surgeon-interpreted-intraoperative-margin-assessment-during-breast-conserving-surgery-on-postoperative-tre-24518https://curecurrent.com/trials/telehealth-intervention-for-symptom-management-and-adherence-to-adjuvant-endocrine-therapy-24519https://curecurrent.com/trials/a-study-of-ly4257496-in-participants-with-cancer-omniray-24520https://curecurrent.com/trials/radial-shock-wave-treatment-alongside-decongestive-care-for-arm-swelling-after-breast-cancer-24521https://curecurrent.com/trials/decision-aid-website-in-helping-to-make-decisions-about-fertility-in-participants-with-cancer-24522https://curecurrent.com/trials/benchmarking-large-language-models-against-tumour-boards-for-oncology-treatment-recommendations-24523https://curecurrent.com/trials/pilot-study-of-aerobic-exercise-during-immune-checkpoint-inhibitor-therapy-in-early-stage-tnbc-24524https://curecurrent.com/trials/auricular-laser-acupuncture-for-improving-sleep-in-breast-cancer-patients-24525https://curecurrent.com/trials/rinatabart-sesutecan-rina-s-pro1184-gen1184-for-advanced-solid-tumors-gct1184-01-pro1184-001-24526https://curecurrent.com/trials/thermal-ablation-and-spine-stereotactic-radiosurgery-in-treating-patients-with-spine-metastases-at-risk-for-compressing-24527https://curecurrent.com/trials/a-study-to-investigate-the-effect-of-omeprazole-and-cyclosporine-on-velzatinib-in-healthy-participants-24528https://curecurrent.com/trials/assessing-benefits-and-harms-of-cannabis-cannabinoid-use-among-cancer-patients-treated-in-community-oncology-clinics-24529https://curecurrent.com/trials/integrating-systematic-patient-reported-evaluations-in-multi-disciplinary-tumor-boards-the-inspire-study-24530https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-efficacy-and-drug-levels-of-bms-986369-golcadomide-in-participants-with-relaps-24531https://curecurrent.com/trials/phase-ib-study-of-alpelisib-with-pembrolizumab-in-patients-with-metastatic-breast-cancer-or-melanoma-selena-24532https://curecurrent.com/trials/biospecimen-and-medical-data-collection-and-tumor-biopsy-in-creating-research-tissue-registry-in-patients-with-inflammat-24533https://curecurrent.com/trials/personalized-exercise-program-for-survivors-of-breast-cancer-steps-bc-trial-24534https://curecurrent.com/trials/a-study-of-sacituzumab-tirumotecan-sac-tmt-mk-2870-as-monotherapy-and-in-combination-with-pembrolizumab-mk-3475-in-parti-24535https://curecurrent.com/trials/ataraxis-real-world-clinical-outcomes-registry-linking-ai-based-pathology-scores-to-patient-outcomes-24536https://curecurrent.com/trials/sacituzumab-tirumotecan-mk-2870-plus-pembrolizumab-versus-tpc-in-tnbc-who-did-not-achieve-pcr-mk-2870-012-24537https://curecurrent.com/trials/a-study-of-sacituzumab-tirumotecan-mk-2870-as-a-single-agent-and-in-combination-with-pembrolizumab-mk-3475-versus-treatm-24538https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-gdc-4198-alone-and-in-combination-with-giredestrant-versus-abemaciclib-and-giredestran-24539https://curecurrent.com/trials/comparison-of-synthetic-mammography-versus-full-field-digital-mammography-in-image-interpretation-and-performance-metric-24540https://curecurrent.com/trials/a-phase-1-2a-study-of-k-1728-in-advanced-solid-tumors-24541https://curecurrent.com/trials/infertility-survey-among-reproductive-age-women-with-gynecological-and-breast-cancer-24542https://curecurrent.com/trials/a-clinical-study-of-sacituzumab-tirumotecan-sac-tmt-mk-2870-in-people-with-breast-cancer-mk-2870-032-24543https://curecurrent.com/trials/comparative-study-of-ql1209-and-perjeta-in-healthy-male-participants-24544https://curecurrent.com/trials/to-study-the-effect-of-inavolisib-in-combination-with-fulvestrant-in-participants-with-breast-cancer-24545https://curecurrent.com/trials/docetaxel-or-paclitaxel-in-reducing-chemotherapy-induced-peripheral-neuropathy-in-african-american-patients-with-stage-i-24546https://curecurrent.com/trials/docetaxel-carboplatin-trastuzumab-and-pertuzumab-with-or-without-estrogen-deprivation-in-treating-patients-with-hormone-24547https://curecurrent.com/trials/blood-biomarkers-for-breast-cancer-treatment-response-24548https://curecurrent.com/trials/a-study-with-nkt3964-for-adults-with-advanced-metastatic-solid-tumors-24549https://curecurrent.com/trials/trial-of-preoperative-radiation-topaz-a-randomized-trial-comparing-hypofractionated-versus-conventionally-fractionated-p-24550https://curecurrent.com/trials/serial-imaging-of-the-novel-radiotracer-18f-fluorthanatrace-18f-ftt-by-pet-ctf-24551https://curecurrent.com/trials/vaccination-of-high-risk-breast-cancer-patients-a-combined-phase-i-ii-feasibility-and-efficacy-study-24552https://curecurrent.com/trials/study-of-changes-in-estrogen-levels-and-grip-strength-in-postmenopausal-women-who-have-received-4-to-6-years-of-hormone-24553https://curecurrent.com/trials/rosetta-breast-01-the-effects-and-safety-of-pumitamig-in-patients-with-triple-negative-breast-cancer-24554https://curecurrent.com/trials/cardioprotective-effect-of-melatonin-versus-vitamin-d-in-breast-cancer-patients-receiving-doxorubicin-24555https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-inavolisib-plus-cdk4-6-inhibitor-and-letrozole-vs-placebo-cdk4-6i-and-letr-24556https://curecurrent.com/trials/a-phase-2-study-of-pcs6422-with-capecitabine-in-patients-with-advanced-or-metastatic-breast-cancer-24557https://curecurrent.com/trials/the-cdk4-6-inhibitor-dosing-knowledge-cdk-study-24558https://curecurrent.com/trials/serratus-plane-block-spb-versus-capsa-cine-versus-botox-a-for-chronic-neuropathic-pain-in-post-mastectomy-syndrome-24559https://curecurrent.com/trials/a-clinical-study-of-patritumab-deruxtecan-to-treat-breast-cancer-mk-1022-016-24560https://curecurrent.com/trials/abemaciclib-ly2835219-plus-fulvestrant-compared-to-placebo-plus-fulvestrant-in-previously-treated-breast-cancer-24561https://curecurrent.com/trials/weight-management-and-health-behavior-intervention-in-lowering-cancer-risk-for-brca-positive-and-lynch-syndrome-families-24562https://curecurrent.com/trials/study-of-patritumab-deruxtecan-with-other-anticancer-agents-in-participants-with-her2-positive-breast-cancer-that-has-sp-24563https://curecurrent.com/trials/a-phase-ii-study-evaluating-the-efficacy-and-safety-of-inavolisib-plus-ribociclib-plus-fulvestrant-versus-placebo-plus-r-24564https://curecurrent.com/trials/ro7771950-versus-tucatinib-in-combination-with-trastuzumab-and-capecitabine-in-people-with-locally-advanced-or-metastati-24565https://curecurrent.com/trials/a-single-arm-phase-ii-study-of-adjuvant-endocrine-therapy-pertuzumab-and-trastuzumab-for-patients-with-anatomic-stage-i-24566https://curecurrent.com/trials/a-study-to-investigate-mechanisms-of-resistance-to-breast-cancer-therapies-24567https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-multiple-treatment-combinations-in-participants-with-breast-cancer-24568https://curecurrent.com/trials/monitoring-for-cardiotoxicity-using-wearable-devices-while-undergoing-cancer-treatments-mct-wave-24569https://curecurrent.com/trials/first-line-sacituzumab-govitecan-in-advanced-untreated-triple-negative-breast-cancer-patients-24570https://curecurrent.com/trials/comparative-performance-of-molecular-breast-imaging-mbi-to-magnetic-resonance-imaging-mri-of-the-breast-in-identifying-a-24571https://curecurrent.com/trials/the-vanguard-study-testing-a-new-way-to-screen-for-cancer-24572https://curecurrent.com/trials/carboplatin-and-paclitaxel-with-or-without-panitumumab-in-treating-patients-with-invasive-triple-negative-breast-cancer-24573https://curecurrent.com/trials/every-day-counts-a-lifestyle-program-for-women-with-metastatic-breast-cancer-24574https://curecurrent.com/trials/development-of-assist-tool-for-breast-examination-using-the-principle-of-ultrasonic-sensor-24575https://curecurrent.com/trials/a-study-to-evaluate-the-effectiveness-and-safety-of-inavolisib-in-participants-with-endocrine-resistant-pik3ca-mutated-h-24576https://curecurrent.com/trials/a-phase-1-study-of-bms-986500-as-monotherapy-or-combination-therapy-in-advanced-solid-tumors-24577https://curecurrent.com/trials/trial-of-225ac-dotatate-ryz101-in-subjects-with-er-her2-negative-unresectable-or-metastatic-breast-cancer-expressing-sst-24578https://curecurrent.com/trials/prospective-evaluation-of-high-dose-systemic-methotrexate-in-patients-with-breast-cancer-and-leptomeningeal-metastasis-24579https://curecurrent.com/trials/prospective-evaluation-of-breast-conserving-surgery-alone-in-low-risk-ductal-carcinoma-in-situ-dcis-24580https://curecurrent.com/trials/evaluation-of-the-efficacy-and-acceptability-of-a-phytotherapy-combining-devil-s-claw-blackcurrant-and-meadowsweet-for-t-24581https://curecurrent.com/trials/collaborative-research-multiscale-modeling-and-intervention-for-improving-long-term-medication-24582https://curecurrent.com/trials/skipping-hormone-therapy-in-low-risk-early-breast-cancer-24583https://curecurrent.com/trials/effects-of-supervised-aerobic-exercise-on-biomarkers-physical-function-and-quality-of-life-in-breast-cancer-survivors-24584https://curecurrent.com/trials/examining-a-new-insomnia-treatment-for-people-living-with-secondary-breast-cancer-24585https://curecurrent.com/trials/trastuzumab-pertuzumab-with-fulvestrant-and-kurmoxilil-in-hr-her2-early-breast-cancer-24586https://curecurrent.com/trials/a-study-to-investigate-apl-5125-in-adults-with-advanced-solid-tumors-24587https://curecurrent.com/trials/social-health-activity-behaviors-and-quality-of-life-among-young-adult-cancer-survivors-24588https://curecurrent.com/trials/ava6103-in-subjects-with-locally-advanced-or-metastatic-selected-solid-tumors-24589https://curecurrent.com/trials/18f-fes-pet-ct-in-the-treatment-planning-and-response-assessment-of-er-positive-breast-cancer-24590https://curecurrent.com/trials/immune-response-activation-for-the-treatment-of-unresectable-metastatic-colorectal-cancer-or-cea-positive-metastatic-bre-24591https://curecurrent.com/trials/studying-the-effect-of-denosumab-on-preventing-breast-cancer-in-women-with-a-brca1-germline-mutation-24592https://curecurrent.com/trials/effects-of-immune-checkpoint-inhibitors-on-coronary-microvasculature-24593https://curecurrent.com/trials/a-clinical-trial-of-kva12123-tbs-2025-treatment-alone-and-in-combination-with-pembrolizumab-in-advanced-solid-tumors-vis-24594https://curecurrent.com/trials/developing-new-educational-materials-about-genetic-testing-for-a-diverse-group-of-cancer-patients-24595https://curecurrent.com/trials/a-study-of-phst001-in-advanced-solid-tumors-24596https://curecurrent.com/trials/improving-nutrition-and-physical-activity-for-cancer-survivors-tools-to-be-fit-24597https://curecurrent.com/trials/safety-and-feasibility-of-robotic-sp-nipple-sparing-mastectomy-24598https://curecurrent.com/trials/design-and-pilot-implementation-of-a-chatbot-to-support-breast-cancer-screening-among-black-women-24599https://curecurrent.com/trials/a-study-of-mental-health-care-in-people-with-cancer-24600https://curecurrent.com/trials/phase-1-study-of-op-3136-in-advanced-or-metastatic-solid-tumors-24601https://curecurrent.com/trials/reduction-of-neoadjuvant-treatment-in-early-triple-negative-breast-cancer-24602https://curecurrent.com/trials/evaluation-of-an-online-remote-cognitive-battery-for-use-in-cancer-survivorship-24603https://curecurrent.com/trials/molecular-breast-imaging-guidance-for-breast-biopsy-for-patients-with-breast-abnormalities-24604https://curecurrent.com/trials/study-of-iev407-as-single-agent-or-in-combination-in-patients-with-advanced-hr-her2-breast-cancer-24605https://curecurrent.com/trials/breathing-interventions-for-postoperative-breast-surgery-patients-24606https://curecurrent.com/trials/phase-3-study-of-rly-2608-fulvestrant-vs-capivasertib-fulvestrant-as-treatment-for-locally-advanced-or-metastatic-pik3ca-24607https://curecurrent.com/trials/combined-nutrition-and-exercise-interventions-in-women-with-breast-cancer-history-24608https://curecurrent.com/trials/neo-rt-a-study-investigating-whether-changing-the-sequence-of-treatments-starting-radiotherapy-followed-by-hormone-thera-24609https://curecurrent.com/trials/image-guided-de-escalation-of-neo-adjuvant-chemotherapy-in-her2-positive-breast-cancer-the-train-3-study-24610https://curecurrent.com/trials/national-cancer-institute-cancer-moonshot-biobank-24611https://curecurrent.com/trials/study-of-azd9574-as-monotherapy-and-in-combination-with-anti-cancer-agents-in-participants-with-advanced-solid-malignanc-24612https://curecurrent.com/trials/study-of-cardiopulmonary-exercise-testing-in-women-who-have-her2-positive-breast-cancer-with-mild-cardiotoxicity-24613https://curecurrent.com/trials/a-phase-ib-study-of-novel-combination-new-of-low-dose-oral-cyclophosphamide-s-to-potentiate-axatilimab-a-retifanlimab-r-24614https://curecurrent.com/trials/preparing-fim-bcs-a-lifestyle-modification-for-african-american-breast-cancer-survivors-24615https://curecurrent.com/trials/harvesting-cells-for-experimental-cancer-treatments-24616https://curecurrent.com/trials/collection-of-blood-from-patients-with-cancer-other-tumors-or-tumor-predisposition-syndromes-for-genetic-analysis-24617https://curecurrent.com/trials/shr-a1811-versus-trastuzumab-plus-pertuzumab-in-ctdna-positive-her2-positive-early-breast-cancer-after-pathologic-comple-24618https://curecurrent.com/trials/distance-based-exercise-to-preserve-function-and-prevent-disability-24619https://curecurrent.com/trials/a-phase-1-study-of-pln-101095-in-adults-with-advanced-or-metastatic-solid-tumors-24620https://curecurrent.com/trials/shortstop-her2-12-months-vs-6-months-of-her2-targeted-medications-for-people-with-her2-breast-cancer-who-had-a-pathologi-24621https://curecurrent.com/trials/evaluation-of-adherence-to-cell-cycle-inhibitors-used-as-adjuvant-therapy-in-patients-with-localized-breast-cancer-at-hi-24622https://curecurrent.com/trials/t-dm1-pertuzumab-in-pre-op-early-stage-her2-brca-24623https://curecurrent.com/trials/clinical-and-therapeutic-outcomes-by-molecular-subtype-in-breast-cancer-24624https://curecurrent.com/trials/a-study-evaluating-the-safety-pharmacokinetics-and-early-efficacy-of-ava6000-in-solid-tumours-24625https://curecurrent.com/trials/to-live-better-after-breast-cancer-treatment-24626https://curecurrent.com/trials/randomized-controlled-trial-evaluating-the-role-of-exercise-in-women-undergoing-treatment-for-breast-cancer-24627https://curecurrent.com/trials/finding-an-effective-dose-of-gm1-to-reduce-or-prevent-neuropathy-numbness-or-weakness-due-to-treatment-with-paclitaxel-24628https://curecurrent.com/trials/the-evaluation-of-pc14586-in-patients-with-advanced-solid-tumors-harboring-a-tp53-y220c-mutation-pynnacle-24629https://curecurrent.com/trials/targeting-osteosarcopaenia-and-multimorbidity-for-frailty-prevention-24630https://curecurrent.com/trials/tissue-acquisition-and-genomics-analysis-of-breast-cancer-and-other-gynecologic-malignancies-24631https://curecurrent.com/trials/evaluation-of-a-novel-ct-on-rails-or-trilogy-stereotactic-spine-radiotherapy-system-ssrs-24632https://curecurrent.com/trials/immunotherapy-using-tumor-infiltrating-lymphocytes-for-patients-with-metastatic-cancer-24633https://curecurrent.com/trials/a-prospective-evaluation-of-the-peri-operative-hypoxia-in-breast-cancer-24634https://curecurrent.com/trials/study-of-a-novel-indibulin-dosing-schedule-for-the-treatment-of-metastatic-breast-cancer-24635https://curecurrent.com/trials/photoacoustic-imaging-of-the-breast-in-patients-with-breast-cancer-and-healthy-subjects-24636https://curecurrent.com/trials/a-phase-3-study-of-hrs-8080-versus-treatment-chosen-by-physicians-in-locally-advanced-and-metastatic-breast-cancer-24637https://curecurrent.com/trials/tactive-u-a-study-to-learn-about-the-study-medicine-vepdegestrant-when-given-with-other-medicines-in-people-with-advance-24638https://curecurrent.com/trials/improving-utilization-of-supplemental-breast-mri-screening-for-women-with-extremely-dense-breasts-24639https://curecurrent.com/trials/prediction-of-lymphedema-in-patients-with-inflammatory-breastcancer-using-preoperative-bioimpedance-measurements-24640https://curecurrent.com/trials/a-study-to-assess-treatment-patterns-and-treatment-adherence-in-early-her2-positive-breast-cancer-participants-after-tre-24641https://curecurrent.com/trials/a-study-of-ly4052031-in-participants-with-advanced-or-metastatic-urothelial-cancer-or-other-solid-tumors-24642https://curecurrent.com/trials/a-study-on-adding-precisely-targeted-radiation-therapy-stereotactic-body-radiation-therapy-to-the-usual-treatment-approa-24643https://curecurrent.com/trials/breast-imaging-studies-in-women-at-high-genetic-risk-of-breast-cancer-annual-follow-up-study-24644https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-giredestrant-in-combination-with-phesgo-pertuzumab-trastuzumab-and-hyalur-24645https://curecurrent.com/trials/guided-digital-self-hypnosis-solution-for-managing-hot-flashes-in-patients-undergoing-adjuvant-hormone-therapy-24646https://curecurrent.com/trials/a-study-of-dato-dxd-in-inoperable-or-metastatic-hormone-receptor-positive-her2-ihc-0-breast-cancer-24647https://curecurrent.com/trials/randomized-controlled-trial-to-assess-blockade-of-voltage-gated-sodium-channels-during-surgery-in-operable-breast-cancer-24648https://curecurrent.com/trials/neurotization-of-the-nipple-areolar-complex-to-restore-sensation-for-patients-with-breast-cancer-undergoing-nipple-spari-24649https://curecurrent.com/trials/de-escalation-of-axillary-dissection-for-node-positive-breast-cancer-24650https://curecurrent.com/trials/platinum-in-treating-patients-with-residual-triple-negative-breast-cancer-following-neoadjuvant-chemotherapy-24651https://curecurrent.com/trials/adc-based-therapy-accroding-to-her2-heterogeneous-24652https://curecurrent.com/trials/collecting-blood-samples-from-patients-with-and-without-cancer-to-evaluate-tests-for-early-cancer-detection-24653https://curecurrent.com/trials/hereditary-gastric-cancer-syndromes-an-integrated-genomic-and-clinicopathologic-study-of-the-predisposition-to-gastric-c-24654https://curecurrent.com/trials/a-randomized-controlled-trial-of-neoadjuvant-weekly-paclitaxel-versus-weekly-paclitaxel-plus-weekly-carboplatin-in-women-24655https://curecurrent.com/trials/treatment-effects-on-development-of-chemotherapy-induced-peripheral-neuropathy-in-patients-with-cancer-24656https://curecurrent.com/trials/to-check-safety-of-ayurvedic-oral-cannabis-in-breast-and-head-and-neck-cancer-24657https://curecurrent.com/trials/a-study-to-learn-more-about-how-well-treatment-with-sevabertinib-bay-2927088-tablets-works-and-how-safe-it-is-in-partici-24658https://curecurrent.com/trials/clinical-genetic-behavioral-laboratory-and-epidemiologic-characterization-of-individuals-and-families-at-high-risk-of-br-24659https://curecurrent.com/trials/gene-edited-t-regulatory-cells-crg-150-for-the-treatment-of-relapsed-refractory-malignancies-24660https://curecurrent.com/trials/effect-of-eswt-on-breast-cancer-related-lymphedema-24661https://curecurrent.com/trials/a-non-interventional-prospective-study-of-early-her2-negative-high-risk-breast-cancer-and-brca1-2-mutations-prevalence-i-24662https://curecurrent.com/trials/a-study-of-her3-dxd-in-subjects-with-locally-advanced-or-metastatic-solid-tumors-24663https://curecurrent.com/trials/open-label-study-of-bbo-10203-in-subjects-with-advanced-solid-tumors-24664https://curecurrent.com/trials/fit2thrivemb-optimization-of-a-physical-activity-promotion-intervention-for-metastatic-breast-cancer-patients-24665https://curecurrent.com/trials/hormone-therapy-with-or-without-combination-chemotherapy-in-treating-women-who-have-undergone-surgery-for-node-negative-24666https://curecurrent.com/trials/abemaciclib-and-endocrine-therapy-in-older-patients-with-breast-cancer-24667https://curecurrent.com/trials/evaluation-of-alternative-site-goserelin-acetate-injection-for-ovarian-function-suppression-ofs-in-local-and-locally-adv-24668https://curecurrent.com/trials/cardioprotection-effect-of-linagliptin-24669https://curecurrent.com/trials/roll-over-study-to-allow-continued-access-to-ribociclib-24670https://curecurrent.com/trials/pancreatic-nutritional-program-for-weight-loss-in-overweight-obese-patients-with-stage-i-iii-breast-cancer-24671https://curecurrent.com/trials/targeted-therapy-directed-by-genetic-testing-in-treating-patients-with-advanced-refractory-solid-tumors-lymphomas-or-mul-24672https://curecurrent.com/trials/additional-support-program-via-text-messaging-and-telephone-based-counseling-for-breast-cancer-patients-receiving-hormon-24673https://curecurrent.com/trials/study-of-cabozantinib-alone-or-in-combination-with-atezolizumab-to-subjects-with-locally-advanced-or-metastatic-solid-tu-24674https://curecurrent.com/trials/a-phase-2-neoadjuvant-study-of-zanidatamab-in-combination-with-chemotherapy-in-participants-with-her2-positive-breast-ca-24675https://curecurrent.com/trials/reduce-sedentary-behavior-during-cancer-treatment-the-redsedcan-study-24676https://curecurrent.com/trials/survivorship-booklets-with-or-without-individual-telephone-sessions-in-increasing-knowledge-about-the-impact-of-breast-c-24677https://curecurrent.com/trials/horse-assisted-interventions-in-an-oncological-centre-24678https://curecurrent.com/trials/doxorubicin-hydrochloride-cyclophosphamide-and-paclitaxel-with-or-without-bevacizumab-in-treating-patients-with-lymph-no-24679https://curecurrent.com/trials/a-study-of-a166-in-patients-with-advanced-solid-malignant-tumors-24680https://curecurrent.com/trials/exemestane-with-or-without-entinostat-in-treating-patients-with-recurrent-hormone-receptor-positive-breast-cancer-that-i-24681https://curecurrent.com/trials/tailoring-neoadjuvant-therapy-in-hormone-receptor-positive-her2-negative-luminal-breast-cancer-24682https://curecurrent.com/trials/a-study-of-alisertib-in-combination-with-endocrine-therapy-in-patients-with-hr-positive-her2-negative-recurrent-or-metas-24683https://curecurrent.com/trials/study-of-the-effects-of-pembrolizumab-in-patients-with-advanced-solid-tumors-24684https://curecurrent.com/trials/trastuzumab-deruxtecan-stereotactic-radiosurgery-srs-in-her2-breast-cancer-brain-metastases-24685https://curecurrent.com/trials/mirvetuximab-soravtansine-and-gemcitabine-hydrochloride-in-treating-patients-with-fralpha-positive-recurrent-ovarian-pri-24686https://curecurrent.com/trials/a-study-of-patritumab-deruxtecan-her3-dxd-in-combination-with-trastuzumab-deruxtecan-t-dxd-in-participants-with-hr-posit-24687https://curecurrent.com/trials/tamoxifen-citrate-letrozole-anastrozole-or-exemestane-with-or-without-chemotherapy-in-treating-patients-with-invasive-rx-24688https://curecurrent.com/trials/low-dose-aspirin-for-the-prevention-of-postpartum-related-breast-cancer-24689https://curecurrent.com/trials/anti-pd-1-monoclonal-antibody-in-advanced-trastuzumab-resistant-her2-positive-breast-cancer-24690https://curecurrent.com/trials/177lu-betabart-in-patients-with-relapsed-refractory-locally-advanced-inoperable-or-metastatic-solid-tumors-24691https://curecurrent.com/trials/safety-and-effectiveness-of-robotic-assisted-remote-surgery-for-breast-tumors-24692https://curecurrent.com/trials/an-open-label-single-arm-study-of-prophylaxis-for-datopotamab-deruxtecan-dato-dxd-related-stomatitis-in-eligible-patient-24693https://curecurrent.com/trials/prospective-study-of-exercise-regimens-after-treatment-for-breast-cancer-for-hypertrophy-and-conditioning-24694https://curecurrent.com/trials/assessment-of-biosignature-classification-of-dcis-for-radiotherapy-benefit-post-lumpectomy-abcd-rt-24695https://curecurrent.com/trials/phase-ii-single-arm-trial-of-low-dose-capecitabine-in-patients-with-advanced-breast-cancer-24696https://curecurrent.com/trials/the-cancer-connected-access-and-remote-expertise-beyond-walls-program-to-provide-in-home-cancer-treatment-and-improve-tr-24697https://curecurrent.com/trials/long-term-outcomes-of-endoscopic-assisted-vs-conventional-breast-conserving-surgery-in-breast-cancer-patients-after-neoa-24698https://curecurrent.com/trials/a-study-to-learn-about-vepdegestrant-when-given-with-pf-07220060-to-people-with-advanced-or-metastatic-breast-cancer-24699https://curecurrent.com/trials/a-pilot-study-assessing-myokines-during-an-exercise-regimen-after-treatment-for-breast-cancer-24700https://curecurrent.com/trials/fertility-decision-and-outcomes-in-young-women-with-breast-cancer-24701https://curecurrent.com/trials/pre-ispy-phase-i-ii-oncology-platform-program-24702https://curecurrent.com/trials/chinese-herbal-acupoint-application-combined-with-triple-antiemetic-therapy-for-prevention-of-chemotherapy-induced-nause-24703https://curecurrent.com/trials/prospective-study-of-the-prosigna-assay-on-neoadjuvant-clinical-decision-making-in-women-with-hr-her2-breast-cancer-24704https://curecurrent.com/trials/a-real-world-observational-study-of-intratumoral-h101-oncolytic-adenovirus-combined-with-immune-checkpoint-inhibitors-fo-24705https://curecurrent.com/trials/her2-positive-breast-cancer-without-intravenous-neoadjuvant-therapy-24706https://curecurrent.com/trials/an-investigation-into-dielectric-testing-for-the-evaluation-and-characterisation-of-breast-tissue-using-a-novel-time-dom-24707https://curecurrent.com/trials/efficacy-and-safety-of-hyperbaric-oxygen-therapy-in-improving-nab-paclitaxel-induced-peripheral-neuropathy-24708https://curecurrent.com/trials/testing-the-addition-of-anti-cancer-drug-zen003694-zen-3694-and-pd-1-inhibitor-pembrolizumab-to-standard-chemotherapy-na-24709https://curecurrent.com/trials/beamion-bcgc-1-a-study-to-find-a-suitable-dose-of-zongertinib-used-alone-and-in-combination-with-other-treatments-to-tes-24710https://curecurrent.com/trials/a-study-of-a-one-time-counseling-session-to-help-reduce-depression-anxiety-and-distress-in-people-with-cancer-24711https://curecurrent.com/trials/gdf-15-and-its-relationship-with-treatment-related-adverse-events-in-breast-cancer-24712https://curecurrent.com/trials/effectiveness-of-cadai-b-for-breast-24713https://curecurrent.com/trials/effectiveness-of-cadai-b-dx-for-decision-support-in-breast-ultrasound-24714https://curecurrent.com/trials/tucatinib-together-with-pembrolizumab-and-trastuzumab-24715https://curecurrent.com/trials/impact-of-sleep-disturbance-on-cognition-and-quality-of-life-in-breast-cancer-24716https://curecurrent.com/trials/clinical-study-to-evaluate-the-cardioprotective-effect-of-pentoxifylline-against-doxorubicin-induced-cardiotoxicity-in-b-24717https://curecurrent.com/trials/a-study-of-bl-b01d1-plus-an-anti-pd-1-antibody-versus-nab-paclitaxel-plus-an-anti-pd-1-antibody-in-patients-with-previou-24718https://curecurrent.com/trials/network-guided-theta-burst-stimulation-for-breast-cancer-with-chemotherapy-induced-peripheral-neuropathy-clinical-and-fm-24719https://curecurrent.com/trials/melatonin-supplementation-and-exercise-program-in-breast-cancer-women-24720https://curecurrent.com/trials/assessing-the-time-demands-of-cancer-24721https://curecurrent.com/trials/impact-of-robotic-versus-endoscopic-surgery-on-nipple-nerve-function-following-nipple-sparing-mastectomy-for-breast-canc-24722https://curecurrent.com/trials/carboplatin-and-paclitaxel-with-or-without-atezolizumab-before-surgery-in-treating-patients-with-newly-diagnosed-stage-i-24723https://curecurrent.com/trials/conventionally-fractionated-vs-hypofractionated-comprehensive-nodal-irradiation-for-breast-cancer-using-pencil-beam-scan-24724https://curecurrent.com/trials/taking-aim-at-breast-cancer-24725https://curecurrent.com/trials/telemonitoring-platform-cureety-techcare-vs-standard-of-care-for-mtbnc-patients-initiating-a-first-line-treatment-24726https://curecurrent.com/trials/a-study-of-nt-175-in-adult-participants-with-advanced-malignancies-that-are-positive-for-hla-a-02-01-and-the-tp53-r175h-24727https://curecurrent.com/trials/radiation-therapy-with-or-without-olaparib-in-treating-patients-with-inflammatory-breast-cancer-24728https://curecurrent.com/trials/ovarian-suppression-evaluating-subcutaneous-leuprolide-acetate-in-breast-cancer-24729https://curecurrent.com/trials/study-to-evaluate-the-safety-and-tolerability-of-camizestrant-in-combination-with-atirmociclib-in-women-with-advanced-br-24730https://curecurrent.com/trials/proton-radiation-for-stage-ii-iii-breast-cancer-24731https://curecurrent.com/trials/radiation-therapy-and-thymus-function-in-young-women-with-breast-cancer-24732https://curecurrent.com/trials/dissemination-of-breastchoice-aim1-b-24733https://curecurrent.com/trials/multicomponent-prehabilitation-in-older-adults-with-breast-cancer-24734https://curecurrent.com/trials/effects-of-ultrasound-guided-stellate-ganglion-block-and-transcutaneous-auricular-vagus-nerve-stimulation-on-sleep-quali-24735https://curecurrent.com/trials/targeting-aurora-a-kinase-to-overcome-treatment-resistance-in-advanced-hr-her2-breast-cancer-24736https://curecurrent.com/trials/a-phase-1-study-of-im-1617-in-participants-with-advanced-cancer-24737https://curecurrent.com/trials/hippocampal-sparing-whole-brain-radiation-versus-stereotactic-radiation-in-patients-with-5-20-brain-metastases-a-phase-i-24738https://curecurrent.com/trials/a-phase-1-2-trial-of-arv-471-alone-and-in-combination-with-palbociclib-ibrance-in-participants-with-er-her2-locally-adva-24739https://curecurrent.com/trials/a-laser-and-topical-treatment-combination-in-the-vulvo-vaginal-atrophy-management-in-breast-cancer-patients-24740https://curecurrent.com/trials/study-to-assess-the-efficacy-and-safety-of-alpelisib-plus-fulvestrant-in-participants-with-hr-positive-hr-her2-negative-24741https://curecurrent.com/trials/anti-ly6e-exatecan-adc-m7437-in-advanced-solid-tumors-24742https://curecurrent.com/trials/clinical-investigator-initiated-trial-iit-of-pd-l1-targeted-radionuclide-probes-24743https://curecurrent.com/trials/a-master-regulator-of-lipid-associated-macrophage-function-in-cancer-24744https://curecurrent.com/trials/phase-ii-protocol-of-proton-therapy-for-partial-breast-irradiation-in-early-stage-breast-cancer-24745https://curecurrent.com/trials/study-of-ab598-monotherapy-and-combination-therapy-in-participants-with-advanced-cancers-24746https://curecurrent.com/trials/a-study-of-tucatinib-or-placebo-with-trastuzumab-and-pertuzumab-for-metastatic-her2-breast-cancer-24747https://curecurrent.com/trials/emergence-of-predictive-metabolomic-biomarkers-of-response-to-neoadjuvant-chemoimmunotherapy-in-triple-negative-breast-c-24748https://curecurrent.com/trials/ultrasound-guided-microwave-ablation-for-breast-fibroadenoma-safety-and-cosmetic-outcomes-24749https://curecurrent.com/trials/ultra-hypofractionated-irradiation-of-the-whole-breast-wbi-compared-to-partial-breast-irradiation-pbi-24750https://curecurrent.com/trials/dalpicilib-enhanced-vs-standard-endocrine-therapy-in-er-her2-early-breast-cancer-24751https://curecurrent.com/trials/imaging-study-in-metastatic-uc-hr-and-her2-breast-cancer-tnbc-and-nsclc-24752https://curecurrent.com/trials/sbrt-combined-with-pd-1-inhibitor-and-chemotherapy-in-early-stage-tnbc-24753https://curecurrent.com/trials/first-in-human-study-of-atx-295-an-oral-inhibitor-of-kif18a-as-monotherapy-and-in-combination-with-anticancer-therapy-in-24754https://curecurrent.com/trials/srs-abemaciclib-w-wo-imlunestrant-in-the-management-of-hr-her2-breast-ca-brain-metastases-24755https://curecurrent.com/trials/the-application-of-18f-g1-pet-ct-targeting-granzyme-b-in-the-pan-cancer-immunotherapy-24756https://curecurrent.com/trials/dcis-recast-trial-ductal-carcinoma-in-situ-re-evaluating-conditions-for-active-surveillance-suitability-as-treatment-24757https://curecurrent.com/trials/t-dxd-with-or-without-neratinib-for-her2-positive-breast-cancer-with-brain-metastasis-24758https://curecurrent.com/trials/cdk4-6-inhibitors-intensification-for-chemotherapy-omission-in-small-size-high-risk-er-positive-breast-cancer-cinnamon-24759https://curecurrent.com/trials/mk-7684a-with-or-without-other-anticancer-therapies-in-participants-with-selected-solid-tumors-mk-7684a-005-keyvibe-005-24760https://curecurrent.com/trials/study-to-understand-relationship-between-gut-health-and-toxicities-of-hormonal-breast-cancer-treatment-24761https://curecurrent.com/trials/safety-of-withdrawal-of-pharmacological-treatment-for-recovered-her2-targeted-therapy-related-cardiac-dysfunction-24762https://curecurrent.com/trials/exert-bc-protein-protein-supplementation-to-improve-body-composition-after-treatment-for-breast-cancer-24763https://curecurrent.com/trials/breast-mammogram-and-tissue-study-24764https://curecurrent.com/trials/bgb-43395-alone-or-as-part-of-combination-therapies-in-participants-with-breast-cancer-and-other-advanced-solid-tumors-24765https://curecurrent.com/trials/a-comparative-study-of-azd9833-plus-palbociclib-versus-anastrozole-plus-palbociclib-in-patients-with-er-positive-her2-ne-24766https://curecurrent.com/trials/cbd-for-breast-cancer-primary-tumors-24767https://curecurrent.com/trials/an-investigational-study-of-bg-75202-alone-and-in-combination-with-other-therapeutic-agents-in-adults-with-advanced-soli-24768https://curecurrent.com/trials/breast-ultrasound-screening-in-elderly-women-a-multicenter-cluster-randomized-trial-24769https://curecurrent.com/trials/removal-of-the-ovaries-fallopian-tubes-and-ca-125-screening-to-reduce-the-risk-of-ovarian-cancer-in-women-at-increased-g-24770https://curecurrent.com/trials/tcb-vs-ec-t-in-high-risk-er-her2-breast-cancer-24771https://curecurrent.com/trials/a-study-of-lenvatinib-pembrolizumab-and-fulvestrant-in-people-with-breast-cancer-24772https://curecurrent.com/trials/curcumin-in-reducing-joint-pain-in-breast-cancer-survivors-with-aromatase-inhibitor-induced-joint-disease-24773https://curecurrent.com/trials/a-prospective-open-label-randomized-trial-comparing-switch-to-a1811-versus-continued-thp-neoadjuvant-therapy-after-thp-i-24774https://curecurrent.com/trials/artificial-intelligence-ai-based-personalized-exercise-coaching-for-patients-with-breast-cancer-24775https://curecurrent.com/trials/capecitabine-in-low-risk-triple-negative-breast-cancer-24776https://curecurrent.com/trials/administration-of-autologous-t-cells-genetically-engineered-to-express-t-cell-receptors-reactive-against-neoantigens-in-24777https://curecurrent.com/trials/iks014-in-advanced-solid-tumors-that-express-her2-24778https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-inavolisib-plus-fulvestrant-compared-with-alpelisib-plus-fulvestrant-in-pa-24779https://curecurrent.com/trials/understanding-and-predicting-breast-cancer-events-after-treatment-24780https://curecurrent.com/trials/non-invasive-artificial-intelligence-based-platform-monitoring-program-nip-it-24781https://curecurrent.com/trials/bgb-43395-plus-letrozole-versus-cdk4-6i-plus-letrozole-for-patients-with-advanced-or-metastatic-hr-her2-breast-cancer-wh-24782https://curecurrent.com/trials/neoadjuvant-therapy-for-early-triple-negative-breast-cancer-a-response-guided-approach-using-iparomlimab-and-tuvonralima-24783https://curecurrent.com/trials/enhancing-icb-efficacy-through-il-1-inhibition-in-tnbc-24784https://curecurrent.com/trials/collection-of-blood-from-patients-with-cancer-24785https://curecurrent.com/trials/icg-lymphography-changes-before-and-after-radiotherapy-in-breast-cancer-patients-24786https://curecurrent.com/trials/evaluation-of-psma-in-her2-ar-metastatic-breast-cancer-24787https://curecurrent.com/trials/older-breast-cancer-patients-risk-for-cognitive-decline-24788https://curecurrent.com/trials/the-efficacy-of-leucogen-in-preventing-the-risk-of-ribociclib-associated-neutropenia-in-early-breast-cancer-24789https://curecurrent.com/trials/trastuzumab-deruxtecan-ds-8201a-versus-investigator-s-choice-for-her2-low-breast-cancer-that-has-spread-or-cannot-be-sur-24790https://curecurrent.com/trials/evaluation-of-the-acceptability-appropriateness-and-feasibility-usability-of-a-metastatic-breast-cancer-specific-prognos-24791https://curecurrent.com/trials/use-of-magtrace-bracketing-for-excision-of-lesion-and-sentinel-lymph-node-localization-in-breast-conserving-surgery-for-24792https://curecurrent.com/trials/study-of-avzo-021-in-patients-with-advanced-solid-tumors-24793https://curecurrent.com/trials/genomic-services-research-program-24794https://curecurrent.com/trials/solis-single-dose-radiotherapy-with-omission-of-lumpectomy-for-intact-small-breast-cancers-24795https://curecurrent.com/trials/a-phase-2-study-of-cediranib-in-combination-with-olaparib-in-advanced-solid-tumors-24796https://curecurrent.com/trials/ai-based-prognostic-factors-identification-in-early-stage-invasive-lobular-breast-carcinoma-24797https://curecurrent.com/trials/er-reactivation-therapy-for-breast-cancer-24798https://curecurrent.com/trials/t-dxd-with-or-without-bevacizumab-for-her2-low-breast-cancer-with-brain-metastasis-24799https://curecurrent.com/trials/cdk-and-body-composition-study-24800https://curecurrent.com/trials/1-week-versus-3-week-pbi-24801https://curecurrent.com/trials/pd-0332991-and-anastrozole-for-stage-2-or-3-estrogen-receptor-positive-and-her2-negative-breast-cancer-24802https://curecurrent.com/trials/breast-cancer-screening-uptake-a-randomized-controlled-trial-assessing-the-effect-of-a-decisional-aid-24803https://curecurrent.com/trials/a-phase-iii-study-of-dato-dxd-with-or-without-durvalumab-compared-with-investigator-s-choice-of-chemotherapy-in-combinat-24804https://curecurrent.com/trials/group-based-comprehensive-lifestyle-program-for-women-with-metastatic-breast-cancer-24805https://curecurrent.com/trials/apatinib-combined-with-cdk4-6i-in-first-line-treatment-for-hr-her2-snf4-subtype-breast-cancer-24806https://curecurrent.com/trials/study-of-neoadjuvant-olaparib-monotherapy-and-olaparib-and-durvalumab-combination-in-her2-negative-brcam-breast-cancer-24807https://curecurrent.com/trials/improved-successful-retrieval-rate-of-hydromark-plus-breast-biopsy-site-marker-in-comparison-to-hydromark-as-well-as-imp-24808https://curecurrent.com/trials/genomically-guided-radiation-therapy-in-the-management-of-triple-negative-breast-cancer-24809https://curecurrent.com/trials/liquid-biopsy-evaluation-and-repository-development-at-princess-margaret-24810https://curecurrent.com/trials/supervised-exercise-in-women-with-breast-cancer-24811https://curecurrent.com/trials/hiit-following-breast-cancer-chemotherapy-24812https://curecurrent.com/trials/solid-tumor-analysis-for-hla-loss-of-heterozygosity-loh-and-apheresis-for-car-t-cell-manufacturing-24813https://curecurrent.com/trials/artificial-intelligence-ai-based-models-for-biomarkers-prediction-24814https://curecurrent.com/trials/lifestyle-exercise-and-nutrition-lean-trial-on-pathologic-complete-response-in-tnbc-24815https://curecurrent.com/trials/aspen-09-03-a-study-of-evorpacept-in-combination-with-trastuzumab-and-chemotherapy-in-metastatic-her2-positive-breast-ca-24816https://curecurrent.com/trials/effects-of-online-yoga-on-the-quality-of-life-of-breast-cancer-patients-24817https://curecurrent.com/trials/opioid-sparing-effects-of-nurse-delivered-hypnosis-during-breast-cancer-surgery-24818https://curecurrent.com/trials/patient-initiated-follow-up-for-women-after-early-breast-cancer-treatment-lysa2pifu-24819https://curecurrent.com/trials/multicenter-trial-for-eliminating-breast-cancer-surgery-or-radiotherapy-in-exceptional-responders-to-neoadjuvant-systemi-24820https://curecurrent.com/trials/re-challenge-immunotherapy-with-cromolyn-tqb2102-and-panpulimab-in-immune-refractory-triple-negative-breast-cancer-24821https://curecurrent.com/trials/prevention-of-persistent-pain-with-lidocaine-infusions-in-breast-cancer-surgery-plan-24822https://curecurrent.com/trials/study-to-evaluate-ccs1477-in-advanced-tumours-24823https://curecurrent.com/trials/a-study-of-language-interpretation-solutions-for-people-with-breast-cancer-24824https://curecurrent.com/trials/a-study-to-test-inavolisib-treatments-in-participants-with-early-stage-pik3ca-mutated-breast-cancer-24825https://curecurrent.com/trials/nautilus-04-no-axillary-surgical-treatment-in-low-risk-clinically-node-negative-breast-cancer-without-whole-breast-radio-24826https://curecurrent.com/trials/effect-of-a-brassicaceae-enriched-diet-on-menopausal-symptoms-in-women-with-breast-cancer-receiving-antiestrogen-therapy-24827https://curecurrent.com/trials/effects-of-spsip-block-on-perioperati-ve-inflammation-and-tlr4-in-breast-cancer-surgery-24828https://curecurrent.com/trials/fucoidan-for-preventing-chemotherapy-related-fatigue-in-patients-with-gastrointestinal-gynecological-breast-or-lung-canc-24829https://curecurrent.com/trials/copper-cu-64-anti-cea-monoclonal-antibody-m5a-pet-in-diagnosing-patients-with-cea-positive-cancer-24830https://curecurrent.com/trials/daphne-paclitaxel-trastuzumab-pertuzumab-in-her2-positive-bc-24831https://curecurrent.com/trials/combination-chemotherapy-with-or-without-trastuzumab-in-treating-patients-with-stage-ii-or-stage-iii-breast-cancer-24832https://curecurrent.com/trials/niraparib-dostarlimab-in-brca-mutated-breast-cancer-24833https://curecurrent.com/trials/phase-ib-dose-escalation-trial-of-taselisib-gdc-0032-in-combination-with-anti-her2-therapies-in-participants-with-advanc-24834https://curecurrent.com/trials/oral-tamoxifen-vs-tamgel-vs-control-in-women-with-atypical-hyperplasia-lobular-carcinoma-in-situ-or-increased-breast-can-24835https://curecurrent.com/trials/neoadjuvant-inetetamab-and-pyrotinib-and-nab-paclitaxel-for-her2-breast-cancer-24836https://curecurrent.com/trials/virtual-rehabilitation-for-cancer-survivors-24837https://curecurrent.com/trials/a-study-of-an-alternative-treatment-approach-preoperative-radiotherapy-then-mastectomy-then-immediate-reconstruction-sur-24838https://curecurrent.com/trials/cardioprotective-effect-of-empagliflozin-in-breast-cancer-patients-24839https://curecurrent.com/trials/abbreviated-breast-mri-ab-mri-with-golden-angle-radial-compressed-sensing-and-parallel-imaging-grasp-24840https://curecurrent.com/trials/can1012-in-pre-malignant-dcis-and-lcis-24841https://curecurrent.com/trials/a-poc-study-to-evaluate-treatments-efficacy-by-monitoring-mrd-using-ctdna-in-hr-positive-her2-negative-ebc-population-24842https://curecurrent.com/trials/phase-2a-study-of-zw25-in-combination-with-palbociclib-plus-fulvestrant-24843https://curecurrent.com/trials/effect-of-resisted-deep-breathing-and-myofascial-release-in-postmastectomy-24844https://curecurrent.com/trials/phase-1b-2-study-of-tti-101-in-combination-for-patients-with-metastatic-hormone-receptor-positive-and-her2-negative-brea-24845https://curecurrent.com/trials/survival-analysis-of-early-triple-negative-breast-cancer-tnbc-women-treated-with-dose-dense-sequential-adjuvant-chemothe-24846https://curecurrent.com/trials/positron-emission-tomography-pet-imaging-of-chemotherapy-induced-cardiotoxicity-24847https://curecurrent.com/trials/alisertib-with-or-without-fulvestrant-in-treating-patients-with-locally-advanced-or-metastatic-endocrine-resistant-breas-24848https://curecurrent.com/trials/clinical-trial-of-yh32367-in-patients-with-her2-positive-locally-advanced-or-metastatic-solid-tumor-24849https://curecurrent.com/trials/a-study-of-kivu-107-in-participants-with-locally-advanced-or-metastatic-solid-tumors-24850https://curecurrent.com/trials/molecular-breast-imaging-and-digital-breast-tomosynthesis-in-screening-patients-with-dense-breast-tissue-24851https://curecurrent.com/trials/trail-r2-and-her2-bi-specific-chimeric-antigen-receptor-car-t-cells-for-the-treatment-of-metastatic-breast-cancer-24852https://curecurrent.com/trials/discontinuation-of-maintenance-her-2-directed-therapy-in-long-term-survivors-of-metastatic-her-2-positive-breast-cancer-24853https://curecurrent.com/trials/ph2-study-for-optimization-of-adjunct-systemic-therapy-in-her2-patients-molecularpcr-trial-24854https://curecurrent.com/trials/neoadjuvant-endocrine-therapy-palbociclib-avelumab-in-estrogen-receptor-positive-breast-cancer-24855https://curecurrent.com/trials/testing-a-mammography-decision-intervention-in-a-rural-setting-24856https://curecurrent.com/trials/a-study-of-db-1303-bnt323-vs-investigator-s-choice-chemotherapy-in-her2-low-hormone-receptor-positive-metastatic-breast-24857https://curecurrent.com/trials/functional-imaging-in-prediction-of-response-to-abemaciclib-for-advanced-hormone-receptor-positive-her2-negative-breast-24858https://curecurrent.com/trials/protein-needs-study-24859https://curecurrent.com/trials/a-study-to-evaluate-enfortumab-vedotin-in-subjects-with-locally-advanced-or-metastatic-malignant-solid-tumors-ev-202-24860https://curecurrent.com/trials/a-study-to-compare-the-steady-state-bioavailability-of-injectable-letrozole-sie-and-oral-letrozole-in-post-menopausal-wo-24861https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-drug-levels-and-preliminary-efficacy-of-bms-986507-combinations-in-adult-par-24862https://curecurrent.com/trials/personalized-prone-immobilization-for-accelerated-partial-breast-radiotherapy-24863https://curecurrent.com/trials/beyond-study-a-multicentre-prospective-observational-study-of-real-world-treatment-patterns-and-outcomes-of-trastuzumab-24864https://curecurrent.com/trials/response-adapted-omission-of-nodal-boost-in-n3-breast-cancer-after-neoadjuvant-systemic-therapy-24865https://curecurrent.com/trials/autologous-t-cells-genetically-engineered-to-express-receptors-reactive-against-kras-mutations-in-conjunction-with-a-vac-24866https://curecurrent.com/trials/role-of-tumor-microbiota-in-the-response-to-neoadjuvant-therapy-in-patients-affected-by-triple-negative-breast-cancer-24867https://curecurrent.com/trials/a-study-of-rc48-adc-for-the-treatment-of-locally-advanced-or-metastatic-breast-cancer-with-low-expression-of-her2-24868https://curecurrent.com/trials/the-validation-of-icbt-clinical-trial-disease-stress-adjustment-in-breast-cancer-patients-24869https://curecurrent.com/trials/an-optimized-ultrasound-twinkling-marker-for-the-imaging-of-lymph-nodes-in-patients-with-clinically-node-positive-breast-24870https://curecurrent.com/trials/prospective-study-of-sensation-and-satisfaction-in-cancer-and-transgender-mastectomy-patients-24871https://curecurrent.com/trials/fast-and-accurate-breast-cancer-diagnosis-using-nanopore-sequencing-in-tanzania-fast-abcd-sequencing-24872https://curecurrent.com/trials/a-phase-i-dose-escalation-study-of-single-fraction-pre-operative-partial-breast-s-pbi-for-early-stage-breast-cancer-24873https://curecurrent.com/trials/remotely-delivered-cognitive-behavioral-stress-management-for-breast-cancer-r-cbsm-24874https://curecurrent.com/trials/study-of-entrectinib-rxdx-101-in-children-and-adolescents-with-locally-advanced-or-metastatic-solid-or-primary-cns-tumor-24875https://curecurrent.com/trials/intraoperative-ultrasound-guided-vs-wire-guided-vs-magnetic-seed-guided-breast-conserving-surgery-for-non-palpable-tumor-24876https://curecurrent.com/trials/role-of-folic-acid-in-the-management-of-adjuvant-endocrine-therapy-induced-hot-flashes-in-breast-cancer-patients-24877https://curecurrent.com/trials/shape-neoadjuvant-chemotherapy-response-24878https://curecurrent.com/trials/precise-oncology-interventions-in-nutrition-and-training-onpoint-24879https://curecurrent.com/trials/palazestrant-in-combination-with-ribociclib-for-the-first-line-treatment-of-er-her2-advanced-breast-cancer-24880https://curecurrent.com/trials/metarrestin-ml-246-in-subjects-with-metastatic-solid-tumors-24881https://curecurrent.com/trials/a-phase-ii-study-of-trastuzumab-deruxtecan-t-dxd-plus-pyrotinib-in-her2-positive-advanced-breast-cancer-after-progressio-24882https://curecurrent.com/trials/intratumoral-n17350-in-advanced-solid-tumors-24883https://curecurrent.com/trials/12-weeks-adjuvant-docetaxel-plus-trastuzumab-in-patients-with-small-node-negative-her2-positive-breast-cancer-sober-24884https://curecurrent.com/trials/signatera-guided-cdk4-6-inhibitor-therapy-in-breast-cancer-24885https://curecurrent.com/trials/phase-iii-study-to-assess-azd9833-cdk4-6-inhibitor-in-hr-her2-mbc-with-detectable-esr1m-before-progression-serena-6-24886https://curecurrent.com/trials/pilot-study-of-the-expansion-of-the-dora-breast-cancer-screening-programme-24887https://curecurrent.com/trials/her2-directed-dendritic-cell-vaccine-during-neoadjuvant-therapy-of-her2-breast-cancer-24888https://curecurrent.com/trials/testing-the-application-of-mepitel-film-during-radiation-therapy-to-reduce-radiation-related-redness-and-peeling-in-brea-24889https://curecurrent.com/trials/a-study-of-asp546c-in-adults-with-gastroesophageal-cancer-pancreatic-cancer-or-other-solid-tumors-24890https://curecurrent.com/trials/hypofractionated-vs-conventionally-fractionated-postmastectomy-radiotherapy-after-implant-based-reconstruction-24891https://curecurrent.com/trials/cognitive-rehabilitation-following-breast-cancer-treatment-24892https://curecurrent.com/trials/a-study-to-confirm-if-fezolinetant-helps-reduce-hot-flashes-in-women-with-breast-cancer-who-are-having-hormone-therapy-24893https://curecurrent.com/trials/community-study-to-increase-mammogram-screening-among-overdue-women-24894https://curecurrent.com/trials/headwaters-gemcitabine-vs-paclitaxel-in-metastatic-triple-negative-breast-cancer-in-women-of-african-ancestry-24895https://curecurrent.com/trials/effect-of-hypnosis-in-the-management-of-anxiety-and-chemo-induced-symptoms-in-adolescents-and-young-adults-with-sarcoma-24896https://curecurrent.com/trials/sexual-funct-on-in-young-women-after-breast-cancer-surgery-24897https://curecurrent.com/trials/cardiovascular-health-education-via-virtual-reality-for-breast-cancer-survivors-receiving-anthracyclines-or-trastuzumab-24898https://curecurrent.com/trials/biopsy-site-marker-in-breast-cancer-24899https://curecurrent.com/trials/enhanced-pain-coping-in-cancer-epic-a-study-of-managing-treatment-related-joint-pain-in-breast-cancer-survivors-24900https://curecurrent.com/trials/artidis-nanomechanical-generated-measurements-for-early-breast-lesions-24901https://curecurrent.com/trials/increasing-patients-engagement-in-breast-cancer-surgery-decision-making-24902https://curecurrent.com/trials/large-language-model-based-emotional-management-for-breast-cancer-patients-24903https://curecurrent.com/trials/caix-targeted-pet-ct-in-solid-tumors-24904https://curecurrent.com/trials/increasing-breast-and-colorectal-cancer-screening-in-the-community-24905https://curecurrent.com/trials/trastuzumab-deruxtecan-and-lovastatin-in-her2-low-and-ultralow-advanced-or-metastatic-breast-cancer-24906https://curecurrent.com/trials/a-study-of-ly4337713-in-participants-with-fap-positive-solid-tumors-24907https://curecurrent.com/trials/intra-operative-radiation-registry-24908https://curecurrent.com/trials/expanded-access-program-to-provide-giredestrant-to-participants-with-er-her2-early-or-locally-advanced-metastatic-breast-24909https://curecurrent.com/trials/ai-based-symptom-management-for-post-treatment-breast-cancer-survivors-24910https://curecurrent.com/trials/evaluate-bl-m17d1-in-patients-w-her2-expressing-mutant-advanced-or-metastatic-solid-tumors-24911https://curecurrent.com/trials/clinico-pathological-and-genomic-features-of-her2-low-early-breast-cancer-24912https://curecurrent.com/trials/phase-i-ii-study-of-the-anti-programmed-death-ligand-1-durvalumab-antibody-medi4736-in-combination-with-olaparib-and-or-24913https://curecurrent.com/trials/senocohort-identification-of-predictive-biomarkers-in-breast-cancer-treatment-24914https://curecurrent.com/trials/estradiol-levels-according-to-body-mass-index-in-premenopausal-patients-with-breast-cancer-24915https://curecurrent.com/trials/a-study-of-68ga-ga-dwj155-in-adult-patients-with-solid-tumors-24916https://curecurrent.com/trials/a-study-of-imlunestrant-ly3484356-in-premenopausal-women-with-estrogen-receptor-positive-er-human-epidermal-growth-facto-24917https://curecurrent.com/trials/a-study-of-tersolisib-ly4064809-stx-478-with-other-anti-cancer-treatments-in-participants-with-advanced-breast-cancer-wi-24918https://curecurrent.com/trials/a-study-of-jnj-101684362-hld-0117-in-patients-with-metastatic-breast-cancer-24919https://curecurrent.com/trials/hypofractionated-radiotherapy-after-breast-reconstruction-for-breast-cancer-24920https://curecurrent.com/trials/clinical-value-of-breast-high-resolution-mr-ductography-in-patients-with-pathological-nipple-discharge-24921https://curecurrent.com/trials/a-phase-ii-study-to-explore-the-safety-tolerability-and-preliminary-antitumor-activity-of-sitravatinib-plus-tislelizumab-24922https://curecurrent.com/trials/circulating-tumor-dna-after-neoadjuvant-chemotherapy-24923https://curecurrent.com/trials/application-of-68ga-labeled-cd73-targeting-probe-pet-ct-imaging-in-the-diagnosis-of-breast-cancer-24924https://curecurrent.com/trials/does-ultrasound-guidance-axillary-incision-improve-sentinel-lymph-node-detection-in-breast-cancer-24925https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-inavolisib-in-combination-with-phesgo-versus-placebo-in-combination-with-24926https://curecurrent.com/trials/the-role-of-simvastatin-in-the-epithelial-mesenchymal-transition-process-of-breast-cancer-24927https://curecurrent.com/trials/first-line-dual-versus-single-her2-targeted-therapy-with-docetaxel-for-advanced-her2-positive-breast-cancer-24928https://curecurrent.com/trials/women-informed-to-screen-depending-on-measures-of-risk-wisdom-study-24929https://curecurrent.com/trials/evaluate-bl-b01d1-in-patients-with-metastatic-or-unresectable-non-small-cell-lung-cancer-nsclc-and-other-solid-tumors-24930https://curecurrent.com/trials/circulating-tumor-dna-24931https://curecurrent.com/trials/study-of-azd5305-as-monotherapy-and-in-combination-with-anti-cancer-agents-in-patients-with-advanced-solid-malignancies-24932https://curecurrent.com/trials/wide-spectrum-micronutrients-supplementation-in-patients-with-cancer-related-fatigue-during-neoadjuvant-and-adjuvant-che-24933https://curecurrent.com/trials/g1t48-an-oral-serd-alone-and-in-combination-with-palbociclib-in-er-positive-her2-negative-advanced-breast-cancer-24934https://curecurrent.com/trials/stereotactic-ablative-radiotherapy-for-oligometastatic-breast-cancer-24935https://curecurrent.com/trials/study-of-3-day-partial-breast-radiation-therapy-in-women-with-breast-cancer-24936https://curecurrent.com/trials/roll-over-study-of-alpelisib-byl719-for-continued-access-and-long-term-safety-24937https://curecurrent.com/trials/an-imaging-technology-contrast-enhanced-mammography-in-predicting-breast-cancer-24938https://curecurrent.com/trials/premedication-with-dexamethasone-for-preventing-interstitial-lung-disease-in-patients-with-breast-cancer-treated-with-tr-24939https://curecurrent.com/trials/precision-navigation-to-improve-community-cancer-screening-participation-24940https://curecurrent.com/trials/study-of-lee011-byl719-and-letrozole-in-advanced-er-breast-cancer-24941https://curecurrent.com/trials/the-effect-of-a-hybrid-approach-in-breast-cancer-education-on-women-s-awareness-fatalism-and-self-compassion-levels-a-ra-24942https://curecurrent.com/trials/real-world-treatment-outcomes-and-safety-of-neoadjuvant-pembrolizumab-containing-therapy-in-patients-with-triple-negativ-24943https://curecurrent.com/trials/alleviation-of-alopecia-in-breast-cancer-patient-using-synbiotics-formula-24944https://curecurrent.com/trials/feasibility-and-identification-of-breast-cancer-patients-for-potential-avoidance-of-surgery-24945https://curecurrent.com/trials/evolutionary-clinical-trial-for-novel-biomarker-driven-therapies-24946https://curecurrent.com/trials/fecal-microbiota-transplantation-in-treating-immune-checkpoint-inhibitor-induced-diarrhea-or-colitis-in-genitourinary-ca-24947https://curecurrent.com/trials/pulsed-electric-field-ablation-for-metastatic-breast-cancer-24948https://curecurrent.com/trials/a-mindfulness-based-self-compassion-program-24949https://curecurrent.com/trials/a-study-of-tislelizumab-combined-with-tac-regimen-as-neoadjuvant-therapy-for-tnbc-24950https://curecurrent.com/trials/genetic-testing-in-predicting-tumor-response-in-patients-with-stage-i-iii-her2-negative-invasive-breast-cancer-24951https://curecurrent.com/trials/identifying-patterns-in-the-breath-of-individuals-with-breast-cancer-24952https://curecurrent.com/trials/study-assessing-the-efficacy-and-safety-of-treatment-with-alpelisib-plus-fulvestrant-in-japanese-men-and-postmenopausal-24953https://curecurrent.com/trials/a-study-to-learn-how-well-participants-with-a-specific-type-of-early-breast-cancer-er-positive-her2-negative-tolerate-an-24954https://curecurrent.com/trials/massage-therapy-in-reducing-chemotherapy-induced-peripheral-neuropathy-in-patients-with-gastrointestinal-or-breast-malig-24955https://curecurrent.com/trials/testing-the-addition-of-radium-therapy-radium-223-dichloride-to-the-usual-chemotherapy-treatment-paclitaxel-for-advanced-24956https://curecurrent.com/trials/stereotactic-ablative-body-radiotherapy-sabr-with-maintenance-of-systemic-therapy-versus-physicians-choice-of-systemic-t-24957https://curecurrent.com/trials/a-study-of-metastases-free-survival-with-saruparib-vs-placebo-added-to-a-standard-rt-adt-in-men-with-high-risk-prostate-24958https://curecurrent.com/trials/wearable-device-tracked-recovery-from-autologous-breast-reconstructive-surgery-24959https://curecurrent.com/trials/selective-axillary-dissection-after-neoadjuvant-chemotherap-yin-patients-with-lymphnode-positive-breast-cancer-24960https://curecurrent.com/trials/a-trial-to-evaluate-efficacy-and-safety-of-ribociclib-with-endocrine-therapy-as-adjuvant-treatment-in-patients-with-hr-h-24961https://curecurrent.com/trials/magseed-enabled-long-term-localization-of-axillary-lymph-nodes-24962https://curecurrent.com/trials/beyond-psychological-distress-implementation-of-a-dyadic-behavioral-intervention-targeting-neuroendocrine-and-mrna-trans-24963https://curecurrent.com/trials/a-first-in-human-clinical-trial-assessing-the-safety-of-es2b-c001-s01-with-or-without-adjuvant-in-patients-with-her2-exp-24964https://curecurrent.com/trials/study-assessing-the-efficacy-and-safety-of-treatment-with-alpelisib-plus-fulvestrant-versus-placebo-plus-fulvestrant-in-24965https://curecurrent.com/trials/argonaut-stool-and-blood-sample-bank-for-cancer-patients-24966https://curecurrent.com/trials/a-study-of-shy-onc6-a-novel-proteasome-inhibitor-in-adults-with-advanced-or-metastatic-solid-tumors-24967https://curecurrent.com/trials/study-of-alpelisib-byl719-in-combination-with-trastuzumab-and-pertuzumab-as-maintenance-therapy-in-patients-with-her2-po-24968https://curecurrent.com/trials/trastuzumab-radiotherapy-impact-on-the-cerebral-prevention-24969https://curecurrent.com/trials/preoperative-accelerated-partial-breast-irradiation-in-patients-with-locally-recurrent-or-second-primary-breast-cancer-24970https://curecurrent.com/trials/atusa-ultrasound-diagnostic-imaging-for-breast-lesions-evaluation-audible-isono-health-24971https://curecurrent.com/trials/adjuvant-radiotherapy-in-breast-with-intensity-modulated-by-tomotherapy-24972https://curecurrent.com/trials/omic-technologies-to-track-resistance-to-palbociclib-in-metastatic-breast-cancer-24973https://curecurrent.com/trials/clinical-study-on-the-application-of-18f-her2-affibody-pet-imaging-in-her2-expressing-breast-cancer-24974https://curecurrent.com/trials/early-assessment-of-the-response-to-neo-adjuvant-chemotherapy-in-breast-cancer-patients-with-fdg-pet-24975https://curecurrent.com/trials/a-phase-1-2-trial-of-ter-2013-in-patients-with-solid-tumors-harboring-akt-pi3k-pten-pathway-alterations-24976https://curecurrent.com/trials/a-clinical-study-to-find-the-optimal-dose-of-an-investigational-treatment-called-bnt323-when-used-in-combination-with-an-24977https://curecurrent.com/trials/alnd-vs-art-in-positive-sentinel-node-after-neoadjuvant-therapy-in-breast-cancer-24978https://curecurrent.com/trials/self-acceptance-and-supportive-accountability-for-active-living-among-adults-receiving-chemotherapy-24979https://curecurrent.com/trials/proteomic-signature-in-breast-cancer-correlation-with-tumor-response-to-neo-adjuvant-chemotherapy-24980https://curecurrent.com/trials/role-of-geriatric-intervention-in-treatment-of-older-patients-with-cancer-prepare-24981https://curecurrent.com/trials/artificial-intelligence-supported-mobile-application-for-patients-with-breast-cancer-24982https://curecurrent.com/trials/breast-cancer-bras-study-breast-cancer-biomechanics-of-radiotherapy-and-surgery-24983https://curecurrent.com/trials/protein-matched-adc-or-pdc-umbrella-trial-in-advanced-pancreatic-and-breast-cancer-24984https://curecurrent.com/trials/a-phase-ii-study-of-hlx22-in-combination-with-trastuzumab-and-chemotherapy-in-her2-positive-locally-advanced-or-metastat-24985https://curecurrent.com/trials/dalpiciclib-plus-toremifene-for-first-line-advanced-hr-positive-and-her2-negative-breast-cancer-24986https://curecurrent.com/trials/icg-vs-blue-patent-for-tad-in-cn1-breast-carcinoma-after-neoadjuvant-chemotherapy-24987https://curecurrent.com/trials/behavioral-activation-for-cancer-related-fatigue-after-breast-cancer-surgery-24988https://curecurrent.com/trials/a-study-of-225ac-ac-aky-1189-in-patients-with-solid-tumors-24989https://curecurrent.com/trials/phase-i-ii-fih-trop2-adc-advanced-unresectable-metastatic-solid-tumors-refractory-to-standard-therapies-kl264-01-24990https://curecurrent.com/trials/pharmacologic-therapies-to-mitigate-radiation-associated-heart-disease-24991https://curecurrent.com/trials/chemotherapy-exemption-in-elderly-women-with-node-positive-er-her2-breast-cancer-24992https://curecurrent.com/trials/pilot-study-of-hydroxychloroquine-for-the-treatment-of-aimss-24993https://curecurrent.com/trials/tad-after-chemotherapy-in-locally-advanced-breast-cancer-24994https://curecurrent.com/trials/gcar1-a-chimeric-antigen-receptor-car-t-cell-therapy-for-relapsed-refractory-gpnmb-expressing-solid-tumours-24995https://curecurrent.com/trials/sentinel-lymph-node-technique-in-multifocal-breast-cancer-24996https://curecurrent.com/trials/phase-ii-study-of-docetaxel-nintedanib-in-breast-cancer-24997https://curecurrent.com/trials/impact-of-systematic-shaving-on-margins-24998https://curecurrent.com/trials/assessing-the-effect-of-an-aerobic-exercise-program-on-vascular-function-in-women-with-non-metastatic-breast-cancer-24999https://curecurrent.com/trials/cardiac-side-effects-of-systemic-therapy-in-early-stage-breast-cancer-25000